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1 GENERAL INTRODUCTION AND OUTLINE 
The amygdala
The amygdala is an almond-shaped brain structure located deep within the human brain. It is part 
of the medial temporal lobe (MTL) and lies in front and on top of the hippocampus (see Fig. 1.1). 
The amygdala was first identified in the early 19th century by Burdach (1819-1826), who originally 
named it “Mandelkern”. Although its name suggests that it is one entity, it actually consists of 
clusters o f several nuclei that appear to form distinct anatomical and functional units (Swanson & 
Petrovich, 1998). Nevertheless, the amygdala has such dense intrinsic connections that it should be 
considered as one structure (see Aggleton, 2000). Besides this more theoretical argument, it has 
also been difficult to investigate the function of specific nuclei because of their relatively small 
volume, particularly in human studies. For example, patients with amygdala damage usually have 
lesions that encompass even larger brain areas than just the amygdala. In addition, the typical 
resolution of functional neuroimaging techniques has been insufficient to detect the function of 
distinct nuclei in healthy humans, although recent high resolution neuroimaging in monkeys 
suggest that this may become possible in the next couple of years (Hoffman, Gothard, Schmid, & 
Logothetis, 2007). Therefore, ‘the amygdala’ is considered one homogeneous structure throughout 
this thesis (unless stated otherwise), even though there is a functional specialization of different 
nuclei and even neuronal populations within nuclei (e.g. Herry et al., 2008).
Studies that have investigated the function of the amygdala date back to the late 19th century, 
when Brown and Schäfer (1888) described the effects o f temporal lobe resection on emotional and 
social behavior in monkeys. This was more systematically investigated by Klüver and Bucy (1939), 
who observed that bilateral resection resulted into “psychic blindness” (or visual agnosia), strong 
tendencies to examine objects orally and to react to every visual stimulus, “marked changes in 
emotional behavior or absence o f emotional reactions in the sense that the motor and vocal 
reactions generally associated with anger and fear are not exhibited”, and increased sexual activity. 
These behavioral symptoms did not occur after unilateral resection, with the exception of 
increased tameness in some monkeys. Later studies using relatively more anatomically specific 
lesions demonstrated that these behavioral symptoms resulted from damage to the amygdala 
(Weiskrantz, 1956). Furthermore, Weiskrantz also showed that these lesions resulted in impaired 
emotional learning. Monkeys with amygdala lesions took about twice as long to learn the 
association between a relatively neutral stimulus and a shock than monkeys with inferior temporal 
lobe lesions.
The amygdala also mediates emotional behavior, social cognition, and memory in humans. 
Initial studies have investigated patients with the rare genetic disease lipoid proteinosis (or Urbach- 
Wiethe disease), who have relatively selective damage to the amygdala due to calcifications in the 
anterior MTL. Those patients are impaired in recognizing the emotional expression of faces 
(Adolphs, Tranel, Damasio, & Damasio, 1994; Thornton et al., 2008), do not exhibit automatic
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bodily responses to stimuli that predict an averse event (i.e., aversive conditioning, Bechara et al.,
1995) which impairs their emotional decision making (Bechara, Damasio, Damasio, & Lee, 1999), 
and do not have better memory for emotional than neutral events as healthy humans do (Cahill, 
Babinsky, Markowitsch, & McGaugh, 1995). The development of functional neuroimaging 
techniques such as Positron Emission Tomography (PET) and functional Magnetic Resonance 
Imaging (fMRI) made it possible to investigate amygdala function also in healthy volunteers. A 
recent meta-analysis over 365 separate neuroimaging studies that reported significant amygdala 
activity concluded that the amygdala is involved in the perception of positive and negative 
emotional stimuli, and preferentially responds to faces that depict emotional expressions (Sergerie, 
Chochol, & Armony, 2008). The amygdala also has a role in a host o f other processes when 
emotion is involved, such as attention, learning, memory, decision making, and social cognition 
(Phelps, 2006).
A current theory suggests that the main role of the amygdala is to modulate an organism’s 
vigilance (Davis & Whalen, 2001; Whalen, 1998). When faced with ambiguous stimuli, the 
amygdala lowers the threshold of sensory systems via feedback projections (Amaral, Behniea, & 
Kelly, 2003; Kapp, Supple, & Whalen, 1994; Vuilleumier, Richardson, Armony, Driver, & Dolan, 
2004), to facilitate the evaluation of those stimuli. This process appears always present (Herry et al., 
2007), and does not depend on conscious awareness of the situation (LeDoux, 1995; Whalen et al., 
2004; Whalen et al., 1998). Moreover, it was recently reported that a patient with amygdala damage 
fails to look at the eyes of others (Adolphs et al., 2005; Spezio, Huang, Castelli, & Adolphs, 2007), 
which suggests that the amygdala is crucial in directing attention towards salient information.
Figure 1.1. The amygdala (in white) and hippocampus (in green) illustrated on a structural Magnetic Resonance 
Imaging (MR!) scan.
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Variability in amygdala reactivity
Normal variability
Despite the consistent involvement of the amygdala in emotion processing, there is a huge 
difference between individuals in the magnitude of their amygdala response, which appears 
relatively stable over time (Johnstone et al., 2005; Manuck, Brown, Forbes, & Hariri, 2007). These 
individual differences are explained in part by stable characteristics known as trait factors. The 
most stable trait is someone’s genetic makeup. Sex, which is determined by a difference of a 
complete chromosome, is probably the most investigated trait, and studies have consistently 
shown that men have larger amygdala responses than women (Sergerie et al., 2008). But even 
differences in single genes already affect amygdala reactivity (Aleman, Swart, & van Rijn, 2008), 
like variations in genes that code for the serotonin transporter (SLC6A4) (Hariri et al., 2002b) or 
catechol-O-methyltransferase (COMT) (Smolka et al., 2005). Also other relatively stable 
characteristics are of influence, such as certain personality characteristics like extraversion (Canli, 
Sivers, Whitfield, Gotlib, & Gabrieli, 2002) and neuroticism (Haas, Omura, Constable, & Canli,
2007), or someone’s age (Gunning-Dixon et al., 2003; Iidaka et al., 2002).
But amygdala reactivity also changes within the same individual under the influence of certain 
conditions, which are known as state factors. Maybe the most investigated state factor that 
influences amygdala function is one’s current mood (Fitzgerald et al., 2008; Schneider et al., 1995). 
Other conditions that affect amygdala reactivity include the occurrence o f a stressful situation (van 
Marle, Hermans, Qin, & Fernández, 2008), or a bad night’s sleep (Yoo, Gujar, Hu, Jolesz, & 
Walker, 2007). But also the mere fluctuation of gonadal steroid hormone levels across the 
menstrual cycle already modulate amygdala responsivity (Goldstein et al., 2005; Ossewaarde, 
Hermans, van Wingen, Backstrom, & Fernández, 2008). Therefore, both state and trait factors 
contribute to the vigor o f one’s amygdala at a certain moment.
Psychiatric disorders
Individual differences in amygdala reactivity are already present in healthy individuals, but are even 
more pronounced in patients with psychiatric disorders. Amygdala hyperresponsivity is part o f the 
pathophysiology of various psychiatric disorders, ranging from anxiety (Rauch, Shin, & Wright,
2003) and mood disorders (Drevets, 2003), to schizophrenia (Hall et al., 2008) and autism (Dalton 
et al., 2005). A study in anxious but healthy individuals suggests that increased amygdala reactivity 
is a trait factor, which implies that individuals with increased amygdala responsivity may be more 
prone to the development of psychiatric disorders (Stein, Simmons, Feinstein, & Paulus, 2007b). 
However, amygdala responsivity is also related to someone’s level o f anxiety at the time of 
investigation (Somerville, Kim, Johnstone, Alexander, & Whalen, 2004), which suggests that state 
anxiety is also important. One approach to investigate whether amygdala hyperreactivity in a
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certain psychiatric disorder is a trait or state factor, is to investigate patients during symptomatic 
and asymptomatic states.
Mood disorders
During a depressive episode, patients with mood disorders have increased amygdala activity during 
rest and higher responses to negative stimuli than healthy individuals (Drevets, 2003). A few 
studies have also investigated asymptomatic patients, to determine whether abnormalities in 
amygdala activity are part of the underlying disease vulnerability (that is, the underlying trait) or 
reflect the current symptoms (that is, the current state). Those studies have shown that recovered 
patients with depression under maintenance pharmacological treatment show normal amygdala 
activity during rest (Drevets et al., 2002; Drevets et al., 1992), and that amygdala hyperresponsivity 
to negative stimuli normalizes during antidepressant therapy (Fu et al., 2004; Sheline et al., 2001). 
This suggests that amygdala hyperactivity mainly coincides with depressive symptoms. However, 
amygdala activity during rest remains elevated in recovered patients who do not use medication 
(Drevets et al., 2002; Drevets et al., 1992), which suggests that increased resting amygdala activity is 
a stable characteristic o f mood disorders, and that the normalization of amygdala hyperactivity 
could be mediated by the medication. Thus, both state and trait factors may contribute to 
abnormal amygdala function in mood disorders.
Outline
The central aim of this thesis was to investigate the contribution o f certain state and trait factors to 
the variability in amygdala function. On the one hand, we investigated the influence of genetic and 
hormonal factors that are involved in the pathophysiology of depression in healthy individuals, to 
explore whether these factors may affect depression vulnerability by influencing amygdala 
functioning. On the other hand, we investigated depressive patients of whom some were depressed 
and others recovered at the time of the investigation, to explore whether abnormal amygdala 
function in major depression is dependent on their mood state, or whether it is a more stable 
characteristic.
The first experiment which is described in Chapter 2 investigated whether individual 
differences in the gene that codes for brain-derived neurotrophic factor (BDNF) affects the role of 
the amygdala in the formation of new memories. BDNF is part o f the family of neurotrophins 
which are all involved in the development and survival of neurons, whereby BDNF appears to be 
the key regulator of the cellular processes that underlie long-term memory (Lu, Christian, & Lu,
2008). Besides its critical role in memory, BDNF is also thought to have a crucial role in the 
etiology o f depression and to mediate antidepressant action (Duman & Monteggia, 2006). 
Importantly for our study, a single modification within the BDNF  gene (Val66Met) that is 
common in humans affects memory performance (Egan et al., 2003) and depression vulnerability 
(Verhagen et al., 2008). Because the amygdala mediates memory for emotional material (LaBar &
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Cabeza, 2006), which is altered during depression (Roberson-Nay et al., 2006), we explored 
whether individual differences in this gene influences memory processing in the amygdala, which 
could be the neural link between its influence on memory and depression vulnerability.
Chapter 3 describes the effects o f moderately elevated progesterone levels on amygdala 
reactivity in healthy young women. Amygdala responsivity already changes across the menstrual 
cycle in healthy women (Ossewaarde et al., 2008), but is augmented in women with premenstrual 
dysphoric disorder (PMDD) (Protopopescu et al., 2008). Whereas also healthy women report 
worse mood prior to the onset o f menstruation, women with PMDD develop such severe negative 
mood symptoms that they are unable to function normally. These symptoms are present when 
progesterone reaches moderate levels during the late stage of the menstrual cycle, and resolve 
when the progesterone concentration has reached a baseline level during the beginning of the next 
menstrual cycle. This modulatory effect appears mediated by the neuroactive progesterone 
metabolite allopregnanolone, which induces negative mood symptoms at moderate concentrations 
(Andreen, Sundström-Poromaa, Bixo, Nyberg, & Bäckström, 2006). To investigate whether this is 
mediated by the amygdala, we directly administered progesterone (which is rapidly converted into 
allopregnanolone) to healthy women and measured amygdala reactivity.
Whereas moderate progesterone and allopregnanolone levels are associated with negative 
mood, high concentrations are mainly associated with impairments of memory. For example, the 
highest progesterone and allopregnanolone concentrations are reached during pregnancy (Luisi et 
al., 2000), when women experience a decrease in memory performance (Brett & Baxendale, 2001; 
Sharp, Brindle, Brown, & Turner, 1993). In Chapter 4, a study is described in which we 
investigated how these high levels of progesterone and allopregnanolone impair memory. Because 
high allopregnanolone levels decrease amygdala function in animals (Akwa, Purdy, Koob, & 
Britton, 1999), we specifically examined how it affects the role of the amygdala in memory 
processing. We therefore again directly administered progesterone. But this time, we waited longer 
before we started the actual experiment, such that the concentrations of progesterone and 
allopregnanolone could increase further to levels that are reached during pregnancy.
Sex hormone levels not only change across the menstrual cycle or pregnancy, but also over 
the course of life. After puberty, the level of the gonadal steroid testosterone decreases with age, in 
both men and women (Vermeulen, 2000; Zumoff, Strain, Miller, & Rosner, 1995). This goes in 
parallel with decreases in amygdala reactivity (Gunning-Dixon et al., 2003; Iidaka et al., 2002), 
which may explain the age-related decreasing prevalence rates of depression (Henderson et al., 
1998). Because testosterone increases amygdala responses in young women (Hermans, Ramsey, & 
van Honk, 2008), we explored whether the age-related changes in amygdala function could be 
mediated by the decline in testosterone concentration. In Chapter 5, we assessed amygdala 
reactivity in healthy young and middle-aged women, and examined the relation between their 
testosterone levels and amygdala activity. But because also many other factors change with age, we 
also directly administered testosterone to the middle-aged women to investigate whether the 
possible relation between testosterone and amygdala activity was indeed mediated by the hormone.
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Finally, a study with depressed patients is described in Chapter 6. Memory processes in the 
amygdala are altered in patients with major depression (Roberson-Nay et al., 2006), but it is unclear 
whether this is related to their depressed mood, or whether it is more related to the underlying 
disease vulnerability. To investigate this, we included patients that experienced their first major 
depressive episode at the time of the investigation, and patients that had recently recovered from 
their first depressive episode, and we compared both groups with healthy volunteers. We 
investigated patients during the early course of depression, because the structural integrity of the 
hippocampus is affected by the experience of multiple episodes (MacQueen et al., 2003), which 
may also influence amygdala processing. Furthermore, because medication also influences 
amygdala activity (Takahashi et al., 2005), the depressed patients were investigated before they 
started with antidepressant treatment, and the recovered patients after they had successfully 
finished pharmacotherapy.
Amygdala activation tasks
To assess amygdala function in these studies, the volunteers performed one o f two different tasks 
while their brain activity was measured with fMRI. The amygdala is involved in various tasks that 
involve emotion (Phelps, 2006), but for our purposes, we used one task that elicits robust 
amygdala activity, and one task to investigate the involvement o f the amygdala in memory 
processing.
The first task took advantage from the crucial involvement of the amygdala in the recognition 
of facial emotion (Adolphs et al., 1994). The task consisted of two different conditions: an emotion 
recognition and a control condition (Hariri et al., 2002b). In the emotion recognition condition, a 
triplet o f angry and fearful faces was presented with one face of either emotion presented above 
one angry and one fearful face (see Fig. 1.2). The volunteers were requested to indicate with a 
button press which of the bottom two faces matched the emotional expression of the face on top. 
In the nonemotional control condition, the faces were replaced by horizontally or vertically 
oriented ellipses, and the volunteers were requested to select the identically oriented ellipse. Neural 
activity related to the perception of emotional faces was identified by comparing neural responses 
elicited by the emotional face condition and the nonemotional control condition. The brain 
regions that typically showed larger responses during the emotion than control condition included 
regions in the occipital and inferior temporal cortex, the inferior frontal gyrus, and the amygdala 
(Fig. 1.3). The occipital and temporal regions are mainly involved in perception of the faces in 
general, the frontal region in the control over task execution, and the amygdala in gleaning the 
emotion from faces. Because the emotion recognition condition combined faces and emotions, 
and the control condition merely consisted of ellipses, the larger amygdala activation does not 
relate to the perception of the specific emotions per se, but rather to its general response to salient, 
biologically relevant stimuli.
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Figure 1.2. The emotional face matching task, adapted from Hariri et al. (2002b) with NimStim stimuli 
(http://www.macbrain.org). In the emotion recognition condition (left), volunteers are requested to identify the 
emotional expression of the faces, and to select one of the bottom two faces that matches the emotional expression of 
the face on top. In the control condition (right), they are requested to select the bottom ellipse that has the same 
geographical orientation as the ellipse on top.
Figure 1.3. Typical activation pattern observed with the emotional face matching task. The left panel shows the 
occipital and inferior temporal cortex on the left and the amygdala in the middle, the middle panel shows the 
amygdala, and the right panel shows the inferior frontal gyrus.
The second task investigated the role of the amygdala in the formation of new memories and 
their retrieval from memory. Because the amygdala is consistently involved in memory processes 
when emotion is involved (LaBar & Cabeza, 2006), we investigated memory for pictures of happy 
and neutral faces. The task consisted of a learning phase and a subsequent test phase. During the 
learning phase, the volunteers studied many male and female face pictures, and indicated the 
gender of the pictures with a button press. Thereafter, during the test phase, the studied pictures 
were presented again intermixed with new pictures, and the volunteers were asked to indicate 
whether they thought a picture was already studied or yet unstudied with a button press (Fig. 1.4). 
Afterwards, the trials were sorted according to whether the volunteer had remembered or 
forgotten them. We then compared neural responses during memory encoding to later
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remembered and later forgotten items (also known as the subsequent memory effect). The 
resulting statistical activation maps identified which brain areas were more active during the 
successful than unsuccessful encoding of items, and therefore revealed which brain areas were 
involved in the formation of new memories.
Figure 1.4. The face memory paradigm. During the initial learning phase (top), the volunteers are requested to 
memorize the faces that are presented, and to make a male/female decision. During the subsequent test phase 
(bottom), the studied faces are presented again, intermixed with yet unstudiedfaces. The volunteers are then requested 
to indicate whether they think they had studied the face, or whether it is a new one.
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The brain regions typically involved in the successful encoding of faces were the intraparietal 
sulcus, the prefrontal cortex, the inferior temporal gyrus, and the amygdala (see Fig. 1.5). The 
intraparietal sulcus is putatively involved in directing attention to the item, the prefrontal cortex in 
the strategic manipulation of the information, the inferior temporal gyrus in face memory trace 
storage, and the amygdala in facilitating all these processes. A similar analysis was performed to 
investigate the neural mechanisms of memory retrieval. The neural responses to remembered and 
forgotten items were compared, to identify which brain areas were involved in the successful 
recognition of faces. The brain regions that were typically activated included the prefrontal cortex, 
which exerts executive control over retrieval attempts, and the ventral striatum, which may reflect 
the rewarding value of recognizing a person encountered before (see Fig. 1.6).
Figure 1.5. Brain regions typically involved in the successful encoding of faces. From left to right: the prefrontal 
cortex, the inferior temporal gyrus, the intraparietal sulcus, and the amygdala.
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ABSTRACT
Brain-derived neurotrophic factor (BDNF) is involved in memory and the pathophysiology of 
depression. Recent animal studies suggest that BDNF mediates memory for emotional experiences 
in the amygdala, which may contribute to its role in memory and depression. A single nucleotide 
polymorphism in the human BDNF  gene (Val66Met) affects hippocampal function and memory 
performance. It also appears to influence depression vulnerability in a sex-specific manner, but 
whether there is a relation with emotional memory is currently unknown. To investigate if BDNF  
Val66Met affects memory processing for biologically salient stimuli, we investigated forty-seven 
healthy volunteers while they memorized and recognized faces during event-related functional 
MRI. No significant differences in memory performance were observed between Val homozygotes 
and Met allele carriers. During memory encoding, Met carriers showed a larger differential 
response between later remembered and later forgotten faces in the amygdala and prefrontal 
cortex. This larger contribution of the amygdala to memory formation in Met carriers was qualified 
by a significant interaction with sex, which revealed that the effect o f BDNF  genotype was specific 
to males. During memory retrieval, Met carriers showed a larger differential response between 
remembered and forgotten faces in the posterior cingulate cortex, and this effect was larger in 
males than females. These results demonstrate that the BDNF  Val66Met polymorphism influences 
specific mnemonic operations underlying encoding and retrieval o f salient stimuli, and suggest less 
efficient memory processing in Met allele carriers. Furthermore, the sex-specific genotype effect in 
the amygdala may contribute to sex-specific effects o f BDNF  Val66Met on depression 
vulnerability.
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INTRODUCTION
Brain-derived neurotrophic factor (BDNF) has an important role in learning and memory 
(Bekinschtein, Cammarota, Izquierdo, & Medina, 2008a; Lu et al., 2008). It regulates activity- 
dependent synaptic plasticity and appears necessary for short- and long-term memory storage 
(Alonso et al., 2002; Bekinschtein et al., 2008b; Figurov, Pozzo-Miller, Olafsson, Wang, & Lu, 
1996; Pang et al., 2004; Patterson et al., 1996). A common single nucleotide polymorphism (SNP) 
in the human BDNF  gene (Val66Met; rs6265), leading to a valine (Val) to methionine (Met) 
substitution in the prodomain of the encoded protein, decreases its activity-dependent secretion 
(Chen et al., 2004; Egan et al., 2003). Consistent with the key roles of BDNF and the hippocampus 
in long-term memory, human carriers o f the Met allele have smaller hippocampal volumes (Bueller 
et al., 2006; Pezawas et al., 2004; Szeszko et al., 2005), show reduced hippocampal activity during 
memory encoding and retrieval (Hariri et al., 2003a; Hashimoto et al., 2008), and demonstrate 
poorer memory performance (Dempster et al., 2005; Egan et al., 2003; Goldberg et al., 2008; Hariri 
et al., 2003a).
Besides the role of BDNF in memory, this neurotrophin and its Val66Met polymorphism are 
also implicated in various psychiatric disorders (Angelucci, Brene, & Mathe, 2005; Duman, 
Heninger, & Nestler, 1997; Neves-Pereira et al., 2005; Neves-Pereira et al., 2002; Thome, Foley, & 
Riederer, 1998). BDNF is thought to have a critical role in the etiology of depression and to 
mediate antidepressant action (Duman et al., 1997; Duman & Monteggia, 2006), although genetic 
association studies with the Val66Met polymorphism have produced inconsistent results (Hwang 
et al., 2006; Schumacher et al., 2005; Strauss et al., 2005; Taylor et al., 2007). However, a recent 
meta-analysis o f BDNF  association studies in depression revealed that male Met allele carriers are 
at increased risk of depression, whereas this association was not observed in females (Verhagen et 
al., 2008). This indicates that the Val66Met polymorphism can have sex-specific effects.
Although BDNF  Val66Met has been associated with both memory and depression, the 
relation between its influence on memory and depression remains unclear. A potential link is the 
amygdala, a brain structure important for emotional memory (LaBar & Cabeza, 2006; McGaugh,
2004). Whereas most BDNF studies have focused on the hippocampus, recent animal studies have 
shown that BDNF also mediates amygdala-dependent fear conditioning (Ou & Gean, 2006; 
Rattiner, Davis, French, & Ressler, 2004). Furthermore, the amygdala is a key brain structure 
implicated in depression (Drevets, 2003; Phillips, Drevets, Rauch, & Lane, 2003b), and it is more 
engaged in the successful encoding of faces and emotional scenes in depressed patients than in 
healthy individuals (Hamilton & Gotlib, 2008; Roberson-Nay et al., 2006). Taken together, these 
studies suggest that the BDNF  Val66Met polymorphism may affect memory processing in the 
amygdala, thereby representing a vulnerability factor for depression.
In the current study, we used face stimuli and event-related functional magnetic resonance 
imaging (fMRI) to investigate whether the BDNF  Val66Met polymorphism influences memory 
processing in the amygdala in healthy volunteers. Faces are biologically salient stimuli, and their
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perception elicits amygdala activity (Fitzgerald, Angstadt, Jelsone, Nathan, & Phan, 2006). 
Importantly, the amygdala is involved in the successful encoding and retrieval o f faces (Sergerie, 
Lepage, & Armony, 2006; van Wingen et al., 2007). By using event-related fMRI, neural responses 
to specific stimuli can be sorted post-hoc according to whether they are remembered or not, and can 
thereby reveal specific successful encoding and retrieval processes.
MATERIALS AND METHODS 
Participants
Genetic and neuroimaging data of 47 volunteers of Caucasian ancestry were acquired (mean age 38 
years; range: 18-53). Participants were physically and mentally healthy as determined by a 
structured interview, free of medication, and right handed. They participated in two independent 
studies, in which the same stimuli and experimental design were used. Twenty-five women and 7 
men were homozygous for the Val allele (68%), and 9 women and 6 men were carrier o f at least 
one Met allele (32%; one woman was homozygous for the Met allele). All procedures were 
approved by the local ethics committee (CMO Regio Arnhem-Nijmegen, The Netherlands), and 
the volunteers gave written informed consent prior to participation.
Face memory paradigm
The experiment consisted of study-test cycles during which the participants were requested to 
memorize and subsequently recognize face pictures (van Wingen et al., 2007). During the study 
phase, the participants were instructed to memorize pictures o f male and female faces, while 
indicating the gender of the stimulus by a button press. During the subsequent test phase, they 
were instructed to recognize these pictures among randomly intermixed new pictures, and made an 
old, new, or unsure decision which they indicated by a button press. The participants completed 
two (N = 11), three (N = 21), or four (N = 15) study-test cycles during scanning. Within each 
study-test cycle, each study phase was immediately followed by the respective test phase. There 
was no significant difference in the number of cycles between genotype groups (%2(2) = 1.4, NS).
The stimuli consisted of faces with a neutral to mildly happy emotional expression and with 
direct gaze direction. They were derived from different stimulus sets (Ekman & Friesen, 1976; 
Lundqvist, Flykt, & Ohman, 1998; Martinez & Benavente, 1998) and the internet. All photos were 
edited to produce oval grayscale pictures that showed the face from chin to forehead and excluded 
the ears. The 960 stimuli were divided over eight study-test blocks of 120 faces each, that did not 
differ in the amount of features (50% male, 24% wearing glasses, 6% with facial hair, and 4% non- 
Caucasian; X2(21) = 1.5, NS). Only two to four of the eight blocks were used per participant. In 
addition, half o f the stimuli per block were used as study items, and half as distractors during test.
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The allocation o f specific stimulus blocks and whether the stimuli were used as study or distractor 
items was counterbalanced across participants. The stimuli were pseudo-randomly intermixed with 
10 null events (2 seconds) per study phase and per test phase, such that there were no more than 
four consecutive presentations per gender or old/new status o f the stimulus. The faces were 
presented for 0.8 seconds with an interstimulus interval o f 3.3-4.3 seconds, during both the study 
and test phase.
Recognition memory performance was assessed using signal detection theory (Snodgrass & 
Corwin, 1988). The discrimination index d’ was calculated as measure for the classification 
accuracy of old/new decisions, and was based on hit and false alarm rates after exclusion of unsure 
responses. Behavioral data were analyzed with BDNF  genotype (ValVal vs. Met carrier) and sex 
(male vs. female) as factors and age as covariate.
MRI data acquisition
Magnetic resonance imaging (MRI) data were acquired with a 1.5 T Siemens (Erlangen, Germany) 
Sonata MR scanner, equipped with a standard head coil. T2*-weighted blood oxygenation level- 
dependent (BOLD) images were acquired using echo-planar imaging (EPI), with each image 
volume consisting o f 33 axial slices (3 mm, 0.5 mm slice-gap, TR = 2.290 s, TE = 30 ms, 64 x 64 
matrix, FOV = 224 mm, FA = 90°). In addition, a high resolution Tl-weighted structural MR 
image was acquired for spatial normalization procedures (3D MP-RAGE, TR = 2250 ms, TE = 
3.93 ms, TI = 850 ms, 176 contiguous 1 mm slices, 256 x 256 matrix, FOV = 256 mm, FA = 15°).
fMRI data analysis
Image analysis was performed with SPM5 (Wellcome Department of Imaging Neuroscience, 
London, UK). The first five EPI-volumes were discarded to allow for T1 equilibration, and the 
remaining images were realigned to the first volume. Images were then coregistered to the 
anatomical scan, corrected for differences in slice acquisition time, spatially normalized to the 
Montreal Neurological Institute (MNI) T1 template, resampled into 2 x 2 x 2 mm3 voxels, and 
spatially smoothed with a Gaussian kernel o f 8 mm FWHM.
Statistical analysis was performed within the framework of the general linear model. Later 
remembered and later forgotten stimuli were separately modeled for the study phase, as were hits, 
misses, correct rejections, and false alarms for the test phase. Stimuli with an incorrect gender 
decision or omission during the study phase, or with an unsure response or omission during test 
phase, were included in a condition o f no interest. The explanatory variables (0.8 seconds) and null 
events (2 seconds) were temporally convolved with the canonical hemodynamic response function 
of SPM5. In addition, the realignment parameters were included to model potential movement 
artifacts, as was a high-pass filter (cut-off at 1/128 Hz). The data were proportionally scaled to 
account for various global effects, and temporal autocorrelation was modeled with an AR(1) 
process. The relevant parameter images contrasting each condition to null events were entered in a
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BDNF  genotype x memory ANOVA with nonsphericity correction for dependent measures. In 
addition, sex was entered as covariate to identify memory clusters unbiased for potential sex 
differences. Statistical tests were family-wise error rate corrected for multiple comparisons across 
the entire brain (p < 0.05), using random field theory-based cluster correction with an initial 
height-threshold of p < 0.005. Mean activity of significant memory clusters was extracted for 
subsequent analyses with BDNF  genotype (ValVal vs. Met carrier) and sex (male vs. female) as 
factors and age as covariate. Peak activations of significant clusters are reported in MNI 
coordinates.
Genotyping
Genetic analyses were carried out at the Department of Human Genetics of the Radboud 
University Nijmegen Medical Centre, in a laboratory which has a quality certification according to 
CCIKL criteria. High molecular weight DNA was isolated from saliva using Oragene containers 
(DNA Genotek, Ottawa, Ontario, Canada) according to the protocol supplied by the 
manufacturer. The BDNF  198-G>A (rs6265) polymorphism (Val66Met) was genotyped using
Taqman® analysis (assay ID: Taqman assay: C__11592758_10; reporter 1: VIC-C-allel, reverse
assay; Applied Biosystems, Nieuwerkerk a/d IJssel, The Netherlands). Genotyping was carried out 
in a volume o f 10 |J.l containing 10 ng of genomic DNA, 5 |J.l o f Taqman Mastermix (2x; Applied 
Biosytems), 0.375 |al o f the Taqman assay and 3.625 |al o f H2O. Genotyping was performed on a 
7500 Fast Real-Time PCR System and genotypes were scored using the algorithm and software 
supplied by the manufacturer (Applied Biosystems). The genotyping assay had been validated 
before use and 5% duplicates and blanks were taken along as quality controls during genotyping. 
Testing for Hardy-Weinberg equilibrium did not show deviations from the expected distribution.
RESULTS 
Behavioral performance
The participants were requested to make a gender decision during memory encoding. No 
significant differences between BDNF  ValVal and Met allele carriers were observed in gender 
classification accuracy (mean ± SEM; Val: 93.9 ± 0.4 %, Met: 93.8 ± 0.7 %; main effect and 
interactions: p > 0.9), or response times (Val: 1082 ± 42 ms, Met: 1151 ± 95 ms; main effect and 
interactions: p > 0.05). Furthermore, no significant differences in memory performance between 
groups were observed (recognition accuracy (d’); Val: 0.84 ± 0.06, Met: 0.85 ± 0.07; main effect and 
interactions: p > 0.7). Response times for memory decisions were fastest for hits and slowest for 
misses (hits (1345 ± 269 ms) < false alarms (1420 ± 296 ms) < correct rejections (1483 ± 294 ms)
< misses (1555 ± 333 ms); F(3,40) = 4.1, p < 0.05), but no significant group effects were observed
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(main effect and interactions; all p > 0.05). These results suggest that neural effects of BDNF  
genotype are unlikely explained by mere differences in behavior.
Imaging results
Memory encoding
The brain regions involved in the successful encoding of faces were identified by comparing 
responses to subsequently remembered and subsequently forgotten items (van Wingen et al., 
2007). This analysis revealed significant clusters in the left amygdala (extending into the anterior 
hippocampus and fusiform gyrus; peak activation of the cluster: [-26, -12, -20], Z = 3.7, pcluster = 
0.004), left middle and inferior frontal gyri ([-38, 6, 52], Z = 3.6, pcluster = 0.008), and left 
intraparietal sulcus ([-38, -60, 50], Z = 5.0, pcluster < 0.001). Mean activity within these clusters was 
extracted for subsequent analyses investigating the effect of the BDNF  Val66Met polymorphism.
In the amygdala, neural activity reflecting successful memory formation as measured by the 
difference between subsequent hits and misses was larger in Met allele carriers than Val 
homozygotes (F(1,42) = 7.7, p = 0.008), and the difference between subsequent hits and misses 
was larger in men than women (F(1,42) = 4.8, p = 0.034). Importantly, these effects were qualified 
by a significant BDNF  genotype x sex interaction (F(1,42) = 7.9, p = 0.007; see Fig. 2.1A). 
Subsequent testing for simple effects showed a significant genotype effect in men (F(1,10) = 8.7, p 
= 0.014), but not in women (p > 0.9). Because the amygdala cluster extended into adjacent areas, 
the same analysis was also performed with the peak voxel within the anatomically defined 
amygdala as dependent variable. This produced similar results (not shown), confirming that the 
BDNF  genotype effects were mediated by the amygdala.
The cluster including the left middle and inferior frontal gyrus also showed a BDNF  genotype 
effect (F(1,42) = 4.4, p = 0.041). Again, the difference between subsequent hits and misses was 
larger in Met carriers than Val homozygotes (see Fig. 2.1B). However, no significant sex effect or 
interaction was observed in this case (p > 0.1). To explore which subregion o f the prefrontal 
cluster mediated the successful encoding effect, the analyses were also performed for the three 
local maxima within the larger cluster. This analysis revealed a significant genotype effect only in 
the superior peak that was also the prefrontal cluster maximum (F(1,42) = 5.1, p = 0.029), 
suggesting that BDNF  genotype modulated successful encoding of faces mainly in the left middle 
frontal gyrus. The cluster in the left intraparietal sulcus only showed an effect of sex (F(1,42) = 7.9, 
p = 0.007), with a larger difference between subsequent hits and misses in men than women, but 
no significant effects of BDNF  genotype.
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Figure 2.1. The BDNF Val66Metpolymorphism affects successful memory encoding of faces in the amygdala, and 
the middle and inferior frontal gyrus. The left panels show sagittal slices at the peak of significant memory clusters 
(i.e., subsequent hits - subsequent misses) for clusters that showed significant BDNF effects (indicated by the white 
boxes; figures p  < 0.005, uncorrected; statistics p  < 0.05, cluster corrected). The right panels show the cluster 
averages for Val homozygotes and Met allele carriers, for males (M) and females (F) separately (i.e., parameter 
estimates; mean ±  SEM). (A) Larger difference between subsequent hits and subsequent misses in Met allele 
carriers than Val homozygotes in the left amygdala are observed in males only (x = -26). (B) Larger difference 
between subsequent hits and subsequent misses in Met allele carriers than Val homozygotes in the left middle and 
inferiorfrontal gyrus in males andfemales (x = -38).
Recognition memory
The brain regions involved in the successful retrieval of faces were identified by comparing 
responses for hits and misses. This analysis revealed significant clusters in the posterior cingulate 
cortex ([-10, -40, 36], Z = 4.1, pciuster = 0.034), caudate nuclei ([8, 6, -2], Z = 4.4, pciuster = 0.007), 
and left inferior frontal gyrus ([-44, 42, 4], Z = 4.3, pcluster = 0.002). Mean activity within these 
clusters was extracted for subsequent investigation of the effect of the BDNF  Val66Met 
polymorphism.
In the posterior cingulate cortex, neural activity reflecting successful memory retrieval as 
measured by the difference between hits and misses was again larger in Met allele carriers than in 
Val homozygotes (F(1,42) = 21.0, p < 0.001), and the difference between hits and misses was 
larger in men than women (F(1,42) = 5.5, p = 0.024). Also here, a significant BDNF  genotype x 
sex interaction was observed (F(1,42) = 5.3, p = 0.027; see Fig. 2.2). Subsequent testing for simple 
effects showed that this interaction was due to a larger genotype effect in men than in women
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(men: F(1,10) = 11.4, p = 0.007; women F(1,31) = 4.0, p = 0.054). The clusters in left inferior 
frontal gyrus and caudate nuclei showed no significant genotype or sex effects (all p > 0.1).
ValVal Met carrier
Figure 2.2. The BDNF Val66Met polymorphism affects successful memory retrieval of faces in the posterior 
cingulate cortex. The left panel shows a sagittal slice at the peak of the significant memory cluster (indicated by the 
white box; i.e., hits - misses) in the left posterior cingulate cortex (x = -10; figure p  < 0.005, uncorrected; statistic p  
< 0.05, cluster corrected), which was the only cluster that showed significant BDNF effects. The right panel shows 
the cluster average for Val homozygotes and Met allele carriers, for males (M) and females (F) separately (i.e., 
parameter estimates; mean ±  SEM). The difference between hits and misses was larger in Met allele carriers than 
Val homozygotes, and this effect was larger in males than females.
DISCUSSION
The results of the current study demonstrate that the BDNF  Val66Met polymorphism affects 
memory formation of biologically salient stimuli in the amygdala and prefrontal cortex, and the 
successful retrieval of those stimuli in the posterior cingulate cortex. Met allele carriers showed 
larger neural activity related to successful memory formation as well as retrieval of faces compared 
to Val homozygotes. In addition, BDNF  gene effects in the posterior cingulate cortex were larger 
in men than women, and appeared specific to males in the amygdala. These results reveal that a 
variation in the human BDNF  gene that affects its activity-dependent secretion (Chen et al., 2004; 
Egan et al., 2003) modulates memory formation as well as retrieval in an event-related manner. 
Furthermore, the influence of BDNF  Val66Met on memory processing in the amygdala and 
posterior cingulate cortex was larger in men than women, supporting sex-dependent effects of 
BDNF  Val66Met.
The larger effects in Met allele carriers compared to Val homozygotes were accompanied by 
equal memory performance. The larger recruitment of neural resources involved in successful 
memory encoding and retrieval in BDNF  Met carriers suggests a reduction of neural efficiency, 
and may reflect a compensatory mechanism to maintain adequate memory performance. Reduced 
neural efficiency appears in line with the facilitatory role of BDNF in the induction of long-term
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potentiation (LTP) (Figurov et al., 1996; Patterson et al., 1996). Because the Met allele is associated 
with reduced activity-dependent secretion (Chen et al., 2004; Egan et al., 2003), a larger neuronal 
population may be required to induce LTP. Moreover, the larger engagement of the prefrontal 
cortex indicates the recruitment of additional neural resources to exert more top-down control 
over encoding processes (Miyashita, 2004; Simons & Spiers, 2003).
Whereas our results show a larger increase in neural activity during successful encoding and 
retrieval in Met allele carriers, previous human imaging studies reported decreased neural activity in 
Met allele carriers during memory encoding and retrieval regardless of memory success (Hariri et 
al., 2003a; Hashimoto et al., 2008). Although the stimulus material and recruited brain regions also 
differed between these studies and ours, these differences are most likely explained by the use of 
different functional imaging designs. Whereas previous studies used blocked designs that measure 
a combination of phasic and tonic activity, we used an event-related design to measure phasic 
responses, which allowed us to dissociate neural responses to (later) remembered and forgotten 
items. The larger successful encoding and retrieval effects in Met allele carriers suggest that the 
reduced neural activity as measured with blocked designs may reflect a reduced neural recruitment 
to maintain an effective encoding or retrieval state (Donaldson, Petersen, Ollinger, & Buckner, 
2001; Otten, Henson, & Rugg, 2002), or higher baseline activity during the control task or during 
rest (Canli et al., 2005; Canli et al., 2006; Heinz et al., 2007; Rao et al., 2007).
BDNF  genotype effects appeared specific to males during memory encoding in the amygdala, 
a brain structure mainly implicated in the relatively automatic facilitation o f memory processes in 
other brain regions during memory encoding (Kensinger & Corkin, 2004; Kilpatrick & Cahill, 
2003; McGaugh, 2004). Furthermore, BDNF  genotype effects were larger in males during memory 
retrieval in the posterior cingulate cortex, a brain region that may shift attention to internally 
generated memory representations (Wagner, Shannon, Kahn, & Buckner, 2005). These differences 
may partly be explained by sex differences in the relative volumes of these brain structures 
(Goldstein et al., 2001), or by fluctuating gonadal steroid hormone levels during the female 
menstrual cycle (Berman et al., 1997; Goldstein et al., 2005; van Wingen et al., 2007; van Wingen et 
al., 2008). In support of the latter possibility, BDNF plasma levels change across the menstrual 
cycle in humans (Begliuomini et al., 2007), and hippocampal BDNF mRNA levels change across 
the estrous cycle in rats (Gibbs, 1998). Moreover, BDNF appears to mediate estradiol’s regulation 
of dendritic spine density in the hippocampus (Murphy, Cole, & Segal, 1998). This regulation of 
BDNF action by cyclical hormone changes may reduce the effect o f BDNF  genotype in women. 
Alternatively, the effect o f BDNF  may be menstrual cycle phase dependent, or modulated by 
hormonal contraceptive use. However, these hormonal factors were not controlled in the current 
study. Future studies may investigate these possibilities, for example by investigating women 
during specific phases of the menstrual cycle.
The current study should be viewed in the light o f some strengths and limitations. The main 
limitation o f this study is the relatively small sample of men and the small sample o f BDNF  Met 
allele carriers, which is due to the low minor allele frequency of the BDNF  Val66Met 
polymorphism. However, the unequal group sizes did not bias the results because the used
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statistics are invariant to the cell frequencies. Nevertheless, one should be careful in interpreting 
the results o f genetic studies until the results are reproduced. Obvious strengths of this study are 
the first application of event-related fMRI to investigate the effects o f BDNF  genotype on 
successful memory encoding and retrieval in humans, and its combination with biologically salient 
stimuli to reveal its influence on memory processing in the amygdala.
The BDNF  Val66Met polymorphism is associated with various neuropsychiatric disorders 
(Hwang et al., 2006; Neves-Pereira et al., 2005; Neves-Pereira et al., 2002). A recent meta-analysis 
of BDNF  association studies suggests that the effect o f the Val66Met polymorphism on the 
etiology of depression is sex-specific, by showing that only male Met allele carriers are at increased 
risk for depression (Verhagen et al., 2008). A key brain structure implicated in depression is the 
amygdala (Drevets, 2003; Phillips et al., 2003b). Analogous to the observation in the current study 
that the contribution of the amygdala to memory formation is largest in male Met allele carriers, 
depressed patients also show increased amygdala activity during the successful encoding of faces 
and negative scenes (Hamilton & Gotlib, 2008; Roberson-Nay et al., 2006). If the larger amygdala 
contribution to memory formation represents a marker for depression vulnerability, this might 
explain why men carrying the Met allele are more at risk of developing depression than Val 
homozygotes, whereas no such association may be present for women.
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3 PROGESTERONE SELECTIVELY INCREASES AMYGDALA REACTIVITY 
IN WOMEN
Guido van Wingen, Frank van Broekhoven, Robbert Jan Verkes, Karl Magnus Petersson, 
Tornjöm Bäckström, Jan Buitelaar, & Guillén Fernández
As published in Molecular Psychiatry (2008), 13, 325-333
ABSTRACT
The acute neural effects of progesterone are mediated by its neuroactive metabolites 
allopregnanolone and pregnanolone. These neurosteroids potentiate the inhibitory actions o f y- 
aminobutyric acid (GABA). Progesterone is known to produce anxiolytic effects in animals, but 
recent animal studies suggest that pregnanolone increases anxiety after a period o f low 
allopregnanolone concentration. This effect is potentially mediated by the amygdala and related to 
the negative mood symptoms in humans that are observed during increased allopregnanolone 
levels. Therefore, we investigated with functional MRI whether a single progesterone 
administration to healthy young women in their follicular phase modulates the amygdala response 
to salient, biologically relevant stimuli. The progesterone administration increased the plasma 
concentrations of progesterone and allopregnanolone to levels that are reached during the luteal 
phase and early pregnancy. The imaging results show that progesterone selectively increased 
amygdala reactivity. Furthermore, functional connectivity analyses indicate that progesterone 
modulated functional coupling o f the amygdala with distant brain regions. These results reveal a 
neural mechanism by which progesterone may mediate adverse effects on anxiety and mood.
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INTRODUCTION
Changes in the blood concentration levels of progesterone and estradiol are associated with 
changes in mood regulation (Steiner, Dunn, & Born, 2003) and cognition (Kimura, 1999). For 
instance, explicit memory (Buckwalter et al., 1999; Keenan, Yaldoo, Stress, Fuerst, & Ginsburg, 
1998; Sharp et al., 1993) and mood (Bennett, Einarson, Taddio, Koren, & Einarson, 2004; 
Buckwalter et al., 1999; Keenan et al., 1998) deteriorate during pregnancy when progesterone and 
estradiol levels reach their highest physiological concentrations. Mood is also influenced by the 
more subtle changes in these hormone levels during the menstrual cycle. The negative mood 
symptoms in premenstrual dysphoric disorder (PMDD) and premenstrual syndrome (PMS) occur 
during the luteal phase, when progesterone and estradiol concentrations are high, and disappear a 
few days after the onset o f menstruation, when these hormone concentrations are lowest 
(Bäckström et al., 1983). However, these negative mood symptoms develop in the absence of 
abnormal gonadal steroid hormone concentrations (Bäckström et al., 1983; Rubinow et al., 1988). 
Furthermore, the administration of progesterone or estradiol after gonadal hormone suppression 
produces negative mood symptoms in women with PMS, but not in women without PMS 
(Schmidt, Nieman, Danaceau, Adams, & Rubinow, 1998). The negative mood in PMDD/PMS 
therefore appears as an abnormal response to normal hormonal changes (Rubinow & Schmidt, 
2006). The neural mechanism by which these hormones influence mood are, however, unknown.
Animal research has shown that progesterone modulates anxiety, and that these effects are 
likely mediated by its metabolite allopregnanolone (Bitran, Shiekh, & Mcleod, 1995; Reddy, 
O'Malley, & Rogawski, 2005; Smith et al., 1998). This neurosteroid potentiates the inhibitory 
actions of y-aminobutyric acid (GABA) by modulation of the GABAA-receptor (Majewska, 
Harrison, Schwartz, Barker, & Paul, 1986). Consistent with this GABAergic mechanism, 
progesterone and allopregnanolone administration usually produce an anxiolytic effect (Bitran et 
al., 1995; Reddy et al., 2005) by action on the amygdala (Akwa et al., 1999). Also pregnanolone, the 
less potent 5ß-stereoisomer of allopregnanolone that has a similar effect (Paul & Purdy, 1992; Zhu, 
Wang, Bäckström, & Wahlström, 2001), can produce anxiolysis (Smith, Ruderman, Frye, 
Homanics, & Yuan, 2006). However, it induces anxiogenic effects to aversive stimuli after a period 
of relative allopregnanolone suppression (Smith et al., 2006), which mimics the low 
allopregnanolone levels during the human follicular phase (Wang, Seippel, Purdy, & Backstrom,
1996). As the amygdala is involved in a wide range of emotional behavior, and local infusions of 
GABA antagonists induce anxiogenic effects (Davis & Whalen, 2001), the amygdala may mediate 
the anxiogenic effects of allopregnanolone as well.
In the present study, we investigated whether a single progesterone administration to healthy 
women during their follicular phase increases amygdala reactivity. The amygdala is part o f a larger 
emotion circuitry, which is important for the identification of the emotional significance of stimuli, 
the generation of an affective response, and emotion regulation (Phillips, Drevets, Rauch, & Lane, 
2003a). We therefore explored whether progesterone’s modulation of amygdala activity influences
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the functional integration of this system. We used an oral administration of micronized 
progesterone, which increases allopregnanolone and pregnanolone concentrations to a similar 
extent (de Lignieres, Dennerstein, & Backstrom, 1995). By administering progesterone instead of 
comparing neural activity during the luteal (high progesterone and estradiol) and the follicular 
phase (low progesterone and estradiol), the results of this study provide a mechanistic account for 
a hormone-brain interaction that is not confounded by (spurious) effects linked to the menstrual 
cycle.
MATERIALS AND METHODS 
Participants
Eighteen naturally cycling women (mean age 24 years; range: 19-39) participated in this study after 
signing informed consent. They were healthy as determined by routine physical and laboratory 
examinations, and had no current psychiatric disorder as measured by a structured interview 
(Sheehan et al., 1998). They were right handed, free o f medication, did not use hormonal 
contraceptives, and reported no history of psychiatric or somatic disease potentially affecting the 
brain. This study was approved by the local ethics committee (CMO Regio Arnhem-Nijmegen, 
The Netherlands).
Design and procedure
The subjects participated twice during the early follicular phase (day 2-7) of different menstrual 
cycles, when endogenous hormone levels are low. They arrived at ~8.15 AM after overnight fast to 
receive a standardized light breakfast, after which 400 mg o f micronized progesterone or placebo 
was administered orally, in a double-blind, cross-over fashion. A venous blood sample was 
collected prior to drug administration and the scanning session, which started ~90 minutes after 
drug intake. In addition, subjects completed a mood rating questionnaire (MRS) (Bond & Lader, 
1974) just prior to scanning and a state anxiety questionnaire (STAI) (Spielberger, Gorsuch, & 
Lushene, 1970) about 190 minutes after drug intake.
Behavioral task
The experimental paradigm consisted of a blocked design, including an emotion condition and a 
visuo-motor control condition. This paradigm has been used previously to investigate drug effects 
on amygdala reactivity (Hariri et al., 2002a; Paulus, Feinstein, Castillo, Simmons, & Stein, 2005). It 
robustly engages the amygdala, by contrasting the response to simultaneously presented angry and 
fearful face stimuli (http://www.macbrain.org) with the response to ellipses (that consisted of
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scrambles of the same face stimuli). The results therefore do not show emotion specific effects, 
but rather a general response to salient, biologically relevant stimuli.
Two emotion blocks were interleaved with three control blocks, and each 30 s block consisted 
of six 5 s trials. Each trial consisted o f three simultaneously presented stimuli, with the cue 
stimulus presented above the target and distractor (see Hariri et al., 2002a). In the emotion 
condition, an angry or fearful face was presented on top as cue, and subjects had to indicate by an 
appropriate button press which of the bottom two faces (one angry and one fearful) matched the 
cue in emotional expression. The three simultaneously presented faces per trial were from different 
persons from the same sex. Half the trials presented faces of men and half o f women, half o f each 
target emotion (angry or fearful). In the control condition, a horizontally or vertically oriented 
ellipse was presented as cue above two ellipses (one vertical and one horizontal), and subjects had 
to select the identically oriented ellipse.
Data acquisition
Scanning was performed with a 1.5 T Siemens Sonata MR scanner (Siemens, Erlangen, Germany), 
equipped with a standard head coil. Seventy-six T2*-weighted EPI-BOLD images were acquired 
per subject with an echo time of 30 ms to reduce signal dropout, with each image volume 
consisting of 33 axial slices (3 mm, 0.5 mm slice-gap, TR = 2.290 s, 64 x 64 matrix, FOV = 224 
mm, FA = 90°). In addition, a high resolution Tl-weighted structural MR image was acquired for 
spatial normalization procedures (MP-RAGE, TR = 2250 ms, TE = 3.93 ms, 176 contiguous 1 
mm slices, 256 x 256 matrix, FOV = 256 mm).
FMRI data analysis
Image analysis was performed with SPM2 (Wellcome Department of Imaging Neuroscience, 
London, UK). The first five EPI-volumes were discarded to allow for T1 equilibration, and the 
remaining images were realigned to the first volume. Images were then corrected for differences in 
slice acquisition time, spatially normalized to the Montreal Neurological Institute T1 template, 
super-sampled into 2 x 2 x 2 mm3 voxels, and spatially smoothed with a Gaussian kernel of 10 
mm FWHM.
Statistical analysis was performed within the framework of the general linear model (Friston et 
al., 1995). For each drug condition, the two experimental conditions were modeled as box-car 
regressors convolved with the canonical hemodynamic response function of SPM2. In addition, 
the realignment parameters were included to model potential movement artifacts as well as a high­
pass filter (cut-off at 1/128 Hz). In order to account for various global effects, the EPI-data was 
proportionally scaled. Temporal autocorrelation was modeled with an AR(1) process and the 
parameter estimates were obtained by maximum likelihood estimation (Friston et al., 2002) to 
allow departures from sphericity. Single-subject parameter images contrasting the emotion and 
control condition were obtained and entered into subsequent random-effects analyses. The main
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effect of task was assessed with a one-sample t-test, and the effect o f drug (i.e., drug-by-task 
interaction) was assessed with a paired t-test. In addition, the effects o f drug on the functional 
integration of the amygdala was investigated using a functional connectivity analysis (Friston et al.,
1997). The time-course of amygdala activity was extracted (i.e., the first eigenvariate of a sphere 
with 6 mm radius around the peak voxel o f the right amygdala as identified by the main effect of 
task), and added as a covariate of interest to the model. Single-subject parameter images containing 
the regression coefficients were obtained and entered into subsequent random-effects analyses. 
One-sample t-tests were used to identify brain regions with a correlated time-course, and paired t- 
tests were used to identify the effects o f drug on functional connectivity with the amygdala. 
Statistical tests were family-wise error (FWE) rate corrected for multiple comparisons across the 
whole brain or the region-of-interest (ROI), using a small volume correction (Worsley et al., 1996), 
unless stated otherwise. The bilateral amygdala ROI was anatomically defined using the WFU 
Pickatlas (Maldjian, Laurienti, Kraft, & Burdette, 2003), and the bilateral face responsive regions in 
the fusiform gyri were defined as spheres with 14 mm radius around previously reported Talairach 
coordinates (Kanwisher, McDermott, & Chun, 1997) that were transformed into MNI-space 
(http://www.mrc-cbu.cam.ac.uk/Imaging/Common/mnispace. shtml). Furthermore, mean 
amygdala activity in both drug conditions was extracted from the bilateral amygdala ROI for 
additional correlation analyses (Brett, Anton, Valbregue, & Poline, 2002).
Serum analysis
Progesterone was measured with Delfia progesterone kits (Wallac Oy, Turku, Finland) according 
to the manufacturer’s instructions. Allopregnanolone was measured with radioimmunoassay (RIA) 
after diethylether extraction and celite chromatography (recovery 78%). The antiserum was 
directed against 3a-hydroxy-20-oxo-5a-pregnan-11-yl carboxymethyl ether-BSA with low cross 
reactivity and a gift from Dr. Robert H. Purdy (Department o f Psychiatry, College of Medicine, 
University o f California, San Diego, CA, USA). The intra-assay coefficient of variation 6.5% and 
inter-assay coefficient of variation o f 8.5% (Andreen et al., 2005).
RESULTS
The baseline plasma concentrations o f progesterone and allopregnanolone did not differ 
significantly between the progesterone and placebo condition (both p > 0.2). The progesterone 
administration increased the progesterone concentration from the follicular to the luteal phase 
range (mean ± SEM, from 1.94 ± 0.29 to 16.83 ± 6.17 nmol/L, t(16) = 2.39, p = 0.03), and 
increased the concentration of allopregnanolone from 0.60 ± 0.05 to 24.98 ± 7.30 nm ol/L  (t(16) = 
3.35, p = 0.004). This allopregnanolone level is similar to that during early pregnancy (Paoletti et 
al., 2006; Parizek et al., 2005). However, progesterone had no significant effect on the mood (Bond
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& Lader, 1974) or state anxiety (Spielberger et al., 1970) questionnaires (all p > 0.2) and did not 
significantly modulate response accuracy or reaction times in the behavioral task (all p > 0.05). 
These factors therefore appear to have little explanatory value in relation to the observed 
differences in brain activity between the progesterone and placebo conditions.
The fMRI results show that the emotion condition yielded larger responses than the control 
condition in the amygdala, ventral visual stream (ranging from the primary visual cortex to the 
fusiform gyrus), inferior frontal gyri, cerebellar vermis, and supplementary motor area (p < 0.05, 
corrected; see Table 3.1 and Fig. 3.1). Critically, progesterone increased the right amygdala 
response (p < 0.05, corrected, see Table 3.1 and Fig. 3.2-3.3). A similar effect was also present in 
the left amygdala, although at a less conservative threshold (see Table 3.1). In contrast, 
progesterone did not significantly influence neural activity in other brain areas.
Fig. 3.1. Larger amygdala responses to salient, biologically relevant stimuli than the control condition in the placebo 
(A) and the progesterone condition (B). The sagittal slices on the left (x = 26) and the maximum intensity 
projections on the right are thresholded atp < 0.001, uncorrected for multiple comparisons.
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Fig. 3.2. A  single progesterone administration increases the amygdala response. A  coronal slice (A) shows the 
increased right amygdala reactivity (y = -6) in the progesterone condition. The maximum intensity projection (B) 
shows the selectivity of the effect. The figures are thresholded at p  < 0.001, uncorrected for multiple comparisons. 
Note that the same effect was observed in the left amygdala at a less conservative statistical threshold
Progesterone Placebo
Fig. 3.3. Mean (±SEM) amygdala reactivity in the progesterone and placebo condition (26, -6, -22).
33
Table 3.1. Cluster maxima for brain regions with a larger response during the emotion than the control condition 
(main effect of task), andfor brain regions that are modulated by progesterone (drug-by-task interaction).
MNI coordinates
x y z
Cluster size t p1
Main effect of task
R inferior occipital gyrus 26 -90 -10 3613 17.9 < 0.001
L inferior occipital gyrus -26 -92 -12 3138 14.1 < 0.001
R amygdala 22 -4 -16 125 9.0 < 0.001
L amygdala -22 -10 -16 164 8.5 < 0.001
R inferior frontal gyrus 44 10 32 575 8.4 < 0.001
L inferior frontal gyrus -44 10 28 240 8.4 < 0.001
Cerebellar vermis 2 -74 -32 63 7.0 0.002
Supplementary motor area 0 10 60 41 6.9 0.002
L inferior frontal gyrus -56 22 -4 22 6.7 0.005
Drug-by-task interaction (progesterone > placebo)
R amygdala 26 -6 -22 14 5.8 0.0012
L amygdala -28 -6 -22 - 2.9 0.0053
1 P-values are corrected for multiple comparisons across the whole brain (p < 0.05, k  > 10).
2 P-value corrected for multiple comparisons across the amygdala (p < 0.05).
3 Peak voxel (p-value is uncorrected for multiple comparisons).
To explore the relation between amygdala reactivity and allopregnanolone levels, state anxiety and 
mood across subjects, additional correlation analyses were performed. While progesterone reliably 
increased amygdala reactivity in the within-subjects comparison, no significant correlations 
between allopregnanolone levels and amygdala activity were observed across subjects during the 
progesterone or placebo conditions. However, progesterone modulated the relation between 
amygdala activity and mood. While amygdala activity was positively correlated with the MRS 
subscales alertness (r = 0.66, p = 0.003) and contentedness (r = 0.53, p = 0.025) during the 
placebo condition, no such relation was observed during the progesterone condition (p > 0.1).
The functional connectivity analysis identified various brain regions that were functionally 
coupled with the right amygdala. Brain regions with a positive correlation with amygdala activity 
included regions in the medial temporal lobe (including the left amygdala and both hippocampi), 
the basal ganglia, orbitofrontal cortex, temporal pole, thalamus, inferior temporal gyri, pons, and 
fusiform gyri. Brain regions in the midbrain and cerebellar vermis showed a negative correlation 
with amygdala activity (p < 0.05, corrected; see Table 3.2).
Progesterone decreased functional connectivity of the fusiform gyrus with the amygdala (p < 
0.05, corrected). Furthermore, the results indicate that progesterone increased functional 
connectivity o f the dorsal anterior cingulate cortex with the amygdala at a less conservative 
threshold (p < 0.001, uncorrected; see Table 3.2 and Fig. 3.4).
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Fig. 3.4. Progesterone modulates functional connectivity of the (A) dorsal anterior cingulate cortex (10, 24, 40) and 
(B) right fusiform gyrus (42, -60, -6) with the amygdala (mean ±SEM ).
DISCUSSION
The results show that a single progesterone administration to healthy women in their follicular 
phase selectively increases amygdala reactivity. The progesterone administration significantly 
increased the plasma concentration of progesterone as well as that of its metabolite 
allopregnanolone, which potentiates the inhibitory actions of GABA (Majewska et al., 1986). 
Because it is this neurosteroid that mediates the acute effects of progesterone (Bitran et al., 1995; 
Reddy et al., 2005), the observed activity increase of the amygdala is likely mediated by the 
neuroactive metabolites allopregnanolone and/or pregnanolone.
The amygdala is critically involved in a wide range of emotional behavior (Phelps & LeDoux,
2005), including fear and anxiety (Davis & Whalen, 2001), and the amygdala displays a pathological 
pattern of responsiveness in certain anxiety (Rauch et al., 2003) and mood disorders (Drevets, 
2003). A previous animal study, in which a relatively large dose of allopregnanolone was infused 
into the central nucleus of the amygdala, has shown that allopregnanolone acts on the amygdala to 
mediate anxiolysis (Akwa et al., 1999). Although the present study does not show an anxiogenic 
effect of allopregnanolone, the results suggest a neural mechanism by which allopregnanolone 
could increase anxiety and worsen mood (i.e., by increasing amygdala activity).
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Table 3.2. Cluster maxima for brain regions that are functionally connected with the right amygdala, and for brain 
regions whose connectivity shows an interaction with progesterone.
MNI coordinates Cluster size t p1
x y z
Positive correlation
MTL, basal ganglia, OFC, -24 0 -16 14025 18.8 < 0.001
temporal pole, thalamus4
R inferior temporal gyrus 62 -54 -8 98 8.6 < 0.001
R inferior occipital gyrus 40 -88 -2 82 7.6 0.001
Pons 12 -32 -42 479 7.1 0.002
L inferior temporal gyrus -52 -64 -8 39 6.3 0.012
L middle temporal gyrus -62 -46 -8 10 6.0 0.026
L fusiform gyrus -48 -64 -10 93 5.5 0.0012
R fusiform gyrus 52 -58 -10 56 5.1 0.0022
Negative correlation
Midbrain -4 -26 -14 151 8.2 < 0.001
Cerebellar vermis 0 -52 -12 57 5.4 0.003
Progesterone > placebo
Anterior cingulate cortex 10 24 40 9 4.7 < 0.0013
Placebo > progesterone
R fusiform gyrus 42 -60 -6 10 5.5 0.0102
1 P-values are corrected for multiple comparisons across the whole brain (p < 0.05, k  > 10).
2 P-values corrected for multiple comparisons across the region-of-interest (p < 0.05).
3 P-value uncorrected fo r multiple comparisons (p < 0.001).
4 MTL: medial tem poral lobe; OFC: orbitofrontal cortex.
Progesterone decreased functional connectivity of the amygdala with the fusiform gyrus, a 
brain region preferentially involved in the processing o f faces (Kanwisher et al., 1997; Tsao, 
Freiwald, Tootell, & Livingstone, 2006). The amygdala projects back to all levels o f the ventral 
visual stream (Amaral et al., 2003), and the amygdala influences activity in this brain region during 
face perception (Vuilleumier et al., 2004), suggesting that progesterone decreases the back- 
projections of the amygdala to the fusiform gyrus. However, because functional connectivity is a 
correlational method, this result may also reflect the influence of the fusiform gyrus on the 
amygdala by feed-forward projections. Furthermore, although the functional integration of the 
emotion circuitry with the amygdala was largely unaltered by progesterone, the results indicate that 
progesterone increased functional coupling of the dorsal anterior cingulate gyrus (dACC) with the 
amygdala. The dACC is activated during the cognitive evaluation of threatening stimuli which
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reduces amygdala activity (Hariri, Mattay, Tessitore, Fera, & Weinberger, 2003b), and is thought to 
support the cognitive control of emotion (i.e., reappraisal) (Ochsner & Gross, 2005). This suggests 
either a progesterone induced change in dACC regulation of amygdala activity, or conversely, the 
influence of the amygdala on regulatory processes. However, this result should be interpreted with 
caution, because the effect did not remain significant after correction for multiple comparisons.
Although progesterone consistently increased amygdala reactivity in a within-subject 
comparison, no significant correlations between allopregnanolone levels and amygdala activity 
were observed across subjects. However, serum allopregnanolone levels do not reflect the 
(regionally specific) availability of this and other neuroactive metabolites in the brain, and 
individual differences in neurosteroid sensitivity may obscure a relation between neurosteroid 
levels and amygdala reactivity when assessed across individuals. Furthermore, while amygdala 
activity was positively correlated to alertness and contentedness in the placebo condition, which 
are two subscales of the mood rating scale that was used, no correlations with state anxiety and 
mood were observed in the progesterone condition. The absence of a relation between amygdala 
reactivity and state anxiety and mood in the progesterone condition could reflect the limitation of 
this study to assess across subject correlations, because the study was designed as a within-subjects 
investigation. In addition, the effects o f progesterone on mood are likely mediated by interactions 
within a larger emotion circuitry (Pezawas et al., 2005). The absence o f a large change in the 
functional integration of the emotion circuitry may therefore explain the absence o f a significant 
change in mood or anxiety.
Two related mechanisms could explain the paradoxical allopregnanolone induced amygdala 
activity increase. First, the hormonal milieu appears to determine the acute effects of the 
neuroactive progesterone metabolites. A study in female mice showed that an otherwise anxiolytic 
dose of pregnanolone increases anxiety to an aversive stimulus after a period of relative 
allopregnanolone suppression, which was accomplished by administering a 5a-reductase inhibitor 
for three days that attenuates the metabolic transformation of progesterone to allopregnanolone 
(Smith et al., 2006). This approach was used to mimic the prolonged low allopregnanolone 
concentration during the human follicular phase (Wang et al., 1996), the menstrual cycle phase 
during which the women in this study were investigated.
Second, allopregnanolone induces a nonlinear behavioral response (Bäckström et al., 2003; 
Miczek, Fish, & De Bold, 2003; N-Wihlbäck, Sundström-Poromaa, & Bäckström, 2006). Low 
doses of allopregnanolone increase aggressive behavior in mice, whereas higher doses decrease 
aggression (Fish, Faccidomo, DeBold, & Miczek, 2001). Moreover, the addition of a low dose of 
progesterone to the treatment with estradiol during hormonal replacement therapy increases 
negative mood, but higher doses do not (Andreen et al., 2006). These negative mood symptoms 
are related to allopregnanolone levels in a bimodal fashion, as these symptoms are only present at 
moderate, but not low or high allopregnanolone concentrations (Andreen et al., 2005; Andreen et 
al., 2006). Furthermore, allopregnanolone levels are lower in PMS patients that respond to 
antidepressant or placebo treatment than non-responders (Freeman, Frye, Rickels, Martin, & 
Smith, 2002). In the present study, an increased responsiveness of the amygdala was observed after
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increasing the progesterone and allopregnanolone concentrations from the follicular phase to 
levels that are naturally occurring during the luteal phase and early pregnancy, respectively (Paoletti 
et al., 2006; Parizek et al., 2005). The increased amygdala response might therefore be specific for 
this concentration change, while higher supra-physiological concentrations might eventually 
decrease amygdala activity (Akwa et al., 1999), in parallel with increased sedation in humans 
(Timby et al., 2006). These results therefore show that changes in progesterone level that are 
within the physiological range can increase amygdala activity.
These two mechanisms are not mutually exclusive but may interact, because the probable 
progesterone dose-dependent amygdala response is likely modulated by the hormonal milieu. In 
this context, it is important to note that during natural hormone fluctuations during the menstrual 
cycle, high progesterone levels occur only in the presence of increased estradiol levels. Thus, the 
threshold for amygdala reactivity likely changes over the menstrual cycle. This suggestion is 
supported by studies showing that the response of healthy women to a pregnanolone dose is larger 
in the luteal than follicular phase (Sundström et al., 1998). Furthermore, women with PMS 
experience more severe symptoms during cycles with high luteal phase progesterone and estradiol 
levels (Hammarbäck, Damber, & Bäckström, 1989), and higher estrogen doses increase negative 
mood symptoms during the progestin phase of hormonal replacement therapy (Björn et al., 2003).
The mechanism by which allopregnanolone could increase amygdala activity is not well- 
understood. However, the paradoxical allopregnanolone induced amygdala activity increase could 
reflect the disinhibition o f the principal neurons of the amygdala via inhibition o f the inhibitory 
interneurons (N-Wihlbäck et al., 2006), a mechanism that has been demonstrated for the 
disinhibitory actions of dopamine (Marowsky, Yanagawa, Obata, & Vogt, 2005). Neurosteroid 
action is brain region and neuron specific, and neurons of the central nucleus of the amygdala 
appear relatively insensitive to allopregnanolone (Belelli et al., 2006). This heterogeneity in 
neurosteroid sensitivity could be mediated by regional differences in receptor subunit composition, 
phosphorylation, and steroid metabolism (Belelli et al., 2006). Specifically, allopregnanolone 
inhibits a4ß2S GABAA-receptors, which reduces tonic inhibition and thereby increases 
excitability. Because this receptor is highly sensitive to neurosteroids, inhibition of this receptor at 
relatively low neurosteroid concentrations can induce paradoxical effects (Shen et al., 2007), and 
may contribute to amygdala disinhibition.
The amygdala has many (largely reciprocal) connections to brain areas that are involved in 
sensory processing, visceral functioning, emotional behavior, and mood (Price, 2003). The 
progesterone induced amygdala activity increase could therefore affect the processing in many 
other brain regions relevant for mood regulation. Studies with depressed patients suggest that 
negative mood is generated by increased activity of brain structures that support the identification 
of the emotional significance o f stimuli and the generation o f an affective response (e.g., the 
amygdala, insula, ventral striatum, and ventral prefrontal cortex), and decreased activity of brain 
structures supporting emotion regulation (e.g., the dorsal prefrontal cortex and hippocampus) 
(Phillips et al., 2003b). The menstrual cycle has been shown to modulate activity in several o f these 
brain regions (Amin, Epperson, Constable, & Canli, 2006; Fernández et al., 2003; Goldstein et al.,
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2005; Protopopescu et al., 2005), suggesting that progesterone and estradiol may influence mood 
by modulating this emotion circuitry. The results of the present study show that progesterone 
increases amygdala activity and indicate that it increases functional coupling with the dACC, 
without affecting the response amplitude in other brain regions. The results of our study therefore 
suggest that progesterone and/or allopregnanolone modulates amygdala activity, and may thereby 
change the functionality of a larger emotion circuitry.
The amygdala is involved in a wide range of emotional behavior, including social cognition 
(Adolphs, 2006) and the stress response (Herman, Ostrander, Mueller, & Figueiredo, 2005), which 
appear to be modulated by progesterone. For example, the modulation of the preference for faces 
during the menstrual cycle appears to be mediated by progesterone (Jones et al., 2005; Penton- 
Voak et al., 1999), as well as the enhancement o f the hypothalamus-pituitary-adrenal (HPA) axis 
response to stressors during the luteal phase (Kirschbaum, Kudielka, Gaab, Schommer, & 
Hellhammer, 1999; Roca et al., 2003). Our results suggest that progesterone could modulate these 
processes by increasing the responsiveness o f the amygdala.
The present study shows that allopregnanolone can have paradoxical effects on amygdala 
activity in healthy women, without influencing anxiety or mood. However, this mechanism could 
mediate the negative effects of allopregnanolone on anxiety and mood in susceptible women. 
Whereas the administration of progesterone or estradiol after gonadal hormone suppression does 
not produce mood changes in healthy women, it produces negative mood symptoms in women 
with PMS (Schmidt et al., 1998). Furthermore, PMS patients have a different sensitivity to 
pregnanolone during the high progesterone luteal phase (Sundström et al., 1998), suggesting that 
allopregnanolone could affect amygdala activity differently in patients with PMDD/PMS. Because 
the amygdala is pathologically activated in certain anxiety (Rauch et al., 2003) and mood disorders 
(Drevets, 2003), we speculate that allopregnanolone might increase amygdala activity to a larger 
extent in women with PMDD/PMS than in healthy women as observed in this study, which could 
explain part of the negative mood symptoms in PMDD/PMS and possibly other gonadal hormone 
related mood disorders.
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ABSTRACT
Progesterone or rather its neuroactive metabolite allopregnanolone modulates amygdala activity, 
and thereby influences anxiety. Also cognition and in particular memory is altered by 
allopregnanolone. In the present study, we investigated whether allopregnanolone modulates 
memory for biologically salient stimuli by influencing amygdala activity, which in turn may affect 
neural processes in other brain regions. A single progesterone dose was administered orally to 
healthy young women in a double-blind, placebo-controlled, crossover design, and participants 
were asked to memorize and recognize faces while undergoing functional MRI. Progesterone 
decreased recognition accuracy without affecting reaction times. The imaging results show that the 
amygdala, hippocampus, and fusiform gyrus supported memory formation. Importantly, 
progesterone decreased responses to faces in the amygdala and fusiform gyrus during memory 
encoding, whereas it increased hippocampal responses. The progesterone induced decrease in 
neural activity in the amygdala and fusiform gyrus predicted the decrease in memory performance 
across subjects. However, progesterone did not modulate the differential activation between 
subsequently remembered and subsequently forgotten faces in these areas. A similar pattern of 
results was observed in the fusiform gyrus and prefrontal cortex during memory retrieval. These 
results suggest that allopregnanolone impairs memory by reducing the recruitment of those brain 
regions that support memory formation and retrieval. Given the important role o f the amygdala in 
the modulation of memory, these results suggest that allopregnanolone alters memory by 
influencing amygdala activity, which in turn may affect memory processes in other brain regions.
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INTRODUCTION
Changes in gonadal steroid hormone levels are associated with changes in mood regulation (Steiner 
et al., 2003) and cognition (Kimura, 1999). For example, the highest physiological levels of 
progesterone and estradiol are reached during pregnancy, which is accompanied by a worsening of 
mood and a decrease in memory performance (Bennett et al., 2004; Buckwalter et al., 1999; de 
Groot, Hornstra, Roozendaal, & Jolles, 2003; Keenan et al., 1998; Sharp et al., 1993). The more 
modest hormone level changes during the menstrual cycle have more subtle and variable effects on 
mood and cognition in healthy women (Hampson, 1990; Maki, Rich, & Rosenbaum, 2002; Phillips 
& Sherwin, 1992; Sveindottir & Backstrom, 2000), but induce negative mood symptoms and 
impair memory in women with premenstrual syndrome (Schmidt et al., 1998; Schmitt et al., 2005). 
These effects are potentially mediated by progesterone’s neuroactive metabolites. The metabolite 
allopregnanolone potentiates the inhibitory effect o f y-aminobutyric acid (GABA) by modulating 
the GABAA-receptor (Majewska et al., 1986), and has been suggested to mediate the negative 
effects of progesterone on mood (N-Wihlback et al., 2006) and memory (Brett & Baxendale, 
2001). Although allopregnanolone can also induce paradoxical effects at moderate concentrations 
(Andreen et al., 2006; Fish et al., 2001; van Wingen et al., 2008), animal studies suggest that 
allopregnanolone usually decreases anxiety (Bitran, Hilvers, & Kellogg, 1991; Bitran et al., 1995; 
Wieland, Lan, Mirasedeghi, & Gee, 1991) and impairs memory (Johansson, Birzniece, Lindblad, 
Olsson, & Backstrom, 2002; Ladurelle et al., 2000), suggesting a possible relation between 
allopregnanolone’s effects on emotion and memory.
Allopregnanolone induces its anxiolytic effect by action on the amygdala (Akwa et al., 1999), a 
brain structure that is known to influence various cognitive processes during emotional 
experiences, including memory formation (Cahill et al., 1996; Canli, Zhao, Brewer, Gabrieli, & 
Cahill, 2000). Animal studies have shown that the amygdala mediates the mnemonic effects of 
GABAergic drugs (Brioni, Nagahara, & McGaugh, 1989). Specifically, the basolateral amygdala 
appears critical in mediating the amnesic effects of benzodiazepines (Tomaz, Dickinson-Anson, & 
McGaugh, 1992). Hence, a modulation of basolateral amygdala activity by progesterone and/or 
allopregnanolone, with putative indirect effects on other brain regions like the hippocampus 
(Richardson, Strange, & Dolan, 2004) or the inferior temporal cortex (ITC), might link hormone 
action with memory performance.
To test this hypothesis, we combined a single progesterone administration to healthy young 
women with functional MRI (fMRI) in a double-blind, placebo-controlled, crossover design. 
During scanning, participants were asked to memorize and recognize faces. The perception of 
faces elicits amygdala activity (Fitzgerald et al., 2006; Somerville et al., 2004), and the amygdala 
modulates the neural response to faces in the fusiform gyrus (Vuilleumier et al., 2004). This brain 
region is preferentially involved in face processing (Kanwisher et al., 1997) and presumably 
involved in face memory storage (Miyashita, 1993). Whereas the amygdala modulates memory 
consolidation in other brain regions (McGaugh, 2004), the prefrontal cortex exerts executive
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control during memory retrieval of visual representations in the ITC (Tomita, Ohbayashi, 
Nakahara, Hasegawa, & Miyashita, 1999). Therefore, we hypothesized that allopregnanolone 
impairs memory for faces by modulating ITC activity, potentially by modulating amygdala activity 
during encoding and prefrontal activity during retrieval.
By adopting a factorial event-related fMRI design we are able to identify the mechanism by 
which allopregnanolone modulates memory formation and retrieval. Initially, we identified brain 
regions supporting memory by comparing neural responses during study and test to items 
remembered or forgotten on the (subsequent) memory test (i.e., main effect o f memory). If 
allopregnanolone impairs memory performance by altering these neural processes it would change 
the differential activation between (subsequent) hits and (subsequent) misses, as reflected by a 
significant drug x memory interaction. Conversely, allopregnanolone may not change these 
memory processes per se, but it may impair memory performance by altering the recruitment of 
these neural processes (cf., Uncapher & Rugg, 2005). Allopregnanolone would then reduce the 
response amplitudes to both (subsequent) hits and (subsequent) misses within those brain regions 
that support memory, as reflected by a significant conjunction between the main effects o f drug 
and memory.
MATERIALS AND METHODS 
Participants
Eighteen women with a mean age of 24 years (range: 19-39) gave written informed consent to 
participate in this study, which had been approved by the local medical ethics committee (CMO 
Regio Arnhem-Nijmegen, The Netherlands). The participants were healthy as determined by 
routine physical and laboratory examinations, had no current neurological or psychiatric disorder 
as measured by a structured interview (MINI) (Sheehan et al., 1998), and reported no history of 
psychiatric or somatic disease potentially affecting the brain. They were right handed, free of 
medication, did not use hormonal contraceptives, and had a regular menstrual cycle. Data of one 
subject were lost because of a technical failure, and data of another were excluded because of 
chance level recognition performance. Therefore, the results are based on the data of sixteen 
participants.
Study design and procedure
Subjects participated twice during the early follicular phase (day 2-7) of different menstrual cycles 
to ensure low endogenous gonadal steroid hormone levels. The estimated median duration 
between sessions was 2.1 (IQR = 1.9) menstrual cycles. They arrived at ~8.15 AM after overnight 
fast to receive a standardized light breakfast, after which 400 mg o f micronized progesterone or
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placebo was administered, in a double-blind, crossover manner. The progesterone dose was 
administered orally, in order to increase the allopregnanolone concentration to a similar extent (de 
Lignieres et al., 1995). Administration was randomized among pairs of subjects, to ensure that the 
order o f versions o f the memory paradigm was the same per subject-pair (see below). A venous 
blood sample was collected before drug administration, before scanning, and after scanning 
(approximately 0, 80, and 190 min relative to the drug administration). In addition, subjects 
completed the mood rating scale (MRS) (Bond & Lader, 1974) prior to scanning, and the state 
version o f the state trait anxiety inventory (STAI) (Spielberger et al., 1970) after scanning. The 
MRS contains 16 visual analogue scales that measure the three principal components alertness 
(scoring range: 0 - 625.2), contentedness (0 - 352.9), and calmness (0 - 152.2). The STAI is a 20 
item 4-point Likert scale that measures state anxiety (20 - 80).
Serum analysis
Progesterone was measured with Delfia progesterone kits (Wallac Oy, Turku, Finland) according 
to the manufacturer’s instructions. Allopregnanolone was measured with a radioimmunoassay 
(RIA) after diethylether extraction and celite chromatography, recovery 78%. The antiserum was 
raised against 3a-hydroxy-20-oxo-5a-pregnan-11-yl carboxymethyl ether-BSA with low cross 
reactivity, a gift from Dr. Robert H. Purdy (Department o f Psychiatry, College of Medicine, 
University o f California, San Diego, CA, USA). The intra-assay coefficient of variation was 6.5% 
and the inter-assay coefficient of variation was 8.5% (Andreen et al., 2005).
Memory paradigm
The subjects completed four study-test cycles during scanning. During study, subjects had to 
memorize pictures of male and female faces, while making a gender decision. During test, they had 
to recognize these pictures among a series o f new pictures, and to make an old, new, or unsure 
decision. For three subjects, only two study-test cycles were available for one session, in which case 
only the respective cycles from the other session were used.
The stimuli consisted of faces with a neutral to mildly happy emotional expression and with 
direct gaze direction. They were derived from different stimulus sets (Ekman & Friesen, 1976) 
(The Karolinska directed emotional faces, D. Lundqvist, A. Flykt, and A. Ohman, 1998, 
Department o f Clinical Neuroscience, Karolinska Institute, Sweden; The AR face database, A. 
Martinez and R. Benavente, 1998, Computer Vision Center, Purdue University, IN) and the 
internet. All photos were edited (Photoshop 6.0, Adobe Systems Inc., San Jose, CA) to produce 
oval grayscale pictures that showed the face from chin to forehead and excluded the ears. The 960 
stimuli were divided over eight blocks of 120 faces each, that did not differ in the amount of 
features (50% male, 24% glasses, 6% facial hair, and 4% non-Caucasian; x2(21) = 1.5, n.s.). Half of 
the stimuli per block were used as study items, and half as distractors during test. In addition, half 
of the blocks were used per session. These two factors were counterbalanced over subject-pairs.
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The stimuli were pseudo-randomly intermixed with 10 null events (2 s) per study and per test 
phase, such that there were no more than four consecutive presentations per gender or old/new 
status of the stimulus. All faces were presented for 0.8 s with an inter stimulus interval o f 3.3 - 4.3 
s. The discrimination index d’ was used as a measure o f recognition accuracy, which was calculated 
as the z-score o f the hit rate minus the z-score of the false alarm rate (Hochhaus, 1972). The hit 
and false alarm rates were defined as the number of hits or false alarms divided by the number of 
old or new trials for which an old or new decision was made.
Image acquisition
MR data were acquired with a 1.5 T Siemens Sonata MR scanner (Siemens, Erlangen, Germany), 
equipped with a standard head coil. Two runs of 854 T2*-weighted EPI-BOLD images were 
acquired, with each image volume consisting of 33 axial slices (3 mm, 0.5 mm slice-gap, TR = 
2.290 s, TE = 30 ms, 64 x 64 matrix, FOV = 224 mm, FA = 90°). In addition, a high resolution 
Tl-weighted structural MR image was acquired for spatial normalization procedures (MP-RAGE, 
TR = 2250 ms, TE = 3.93 ms, 176 contiguous 1 mm slices, 256 x 256 matrix, FOV = 256 mm).
Image analysis
Image analysis was performed with SPM2 (Wellcome Department of Imaging Neuroscience, 
London, UK). The first five EPI-volumes were discarded to allow for T1 equilibration, and the 
remaining images were realigned to the first volume. Images were then corrected for differences in 
slice acquisition time, spatially normalized to the Montreal Neurological Institute T1 template, 
super-sampled into 2 x 2 x 2 mm3 voxels, and spatially smoothed with a Gaussian kernel of 10 
mm FWHM.
Statistical analysis was performed within the framework of the general linear model (Friston et 
al., 1995). Later remembered and later forgotten stimuli were separately modeled for the study 
phase, as were hits, misses, correct rejections, and false alarms for the test phase. Stimuli with an 
incorrect gender decision or omission during study, or with an unsure response or omission during 
test, were included in a condition of no interest. The explanatory variables (0.8 s) and null events (2 
s) were temporally convolved with the canonical hemodynamic response function of SPM2. In 
addition, the realignment parameters were included to model potential movement artifacts as well 
as a high-pass filter (cut-off at 1/128 Hz). In order to account for various global effects, the EPI- 
data was proportionally scaled. Temporal autocorrelation was modeled with an AR(1) process and 
the parameter estimates were obtained by maximum likelihood estimation (Friston et al., 2002) to 
allow for departures from sphericity. The relevant parameter images contrasting each condition to 
null events were entered in a random-effects repeated measures ANOVA with a non-sphericity 
correction. Statistical tests were family-wise error rate corrected for multiple comparisons across 
the whole brain. A small volume correction was used to correct for multiple comparisons across 
the search volume for regions of interest (Worsley et al., 1996). Because the basolateral amygdala
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mediates the amnesic effects o f diazepam (Tomaz et al., 1992), the search volume for the amygdala 
was defined as a sphere with 7 mm radius around the probabilistic cytoarchitectonic center o f the 
basolateral amygdala ([-26 -8 -18] and [28 -8 -18]), which approximates total amygdala volume 
(Amunts et al., 2005; Eickhoff et al., 2005). Correspondingly, the hippocampal search volume was 
defined as a sphere with 10 mm radius around the center of the Cornu ammonis ([-28 -28 -8] and 
[28 -26 -8]). In addition, the face responsive region in the fusiform gyrus was defined as a sphere 
with 10 mm radius around previously reported Talairach coordinates (Kanwisher et al., 1997), that 
were transformed into MNI-space (http://imaging.mrc-cbu.cam.ac.uk/imaging/MniTalairach; [-36 
-64 -16] and [40 -56 -16]). To exclude a general effect o f the drug administration on the BOLD 
response, the primary visual cortex (V1) was used as control region, which was defined analogously 
to the hippocampus (Amunts, Malikovic, Mohlberg, Schormann, & Zilles, 2000). The maxima of 
significant clusters are reported in MNI coordinates.
Hypothesis testing
Statistical tests were performed separately for encoding and retrieval. The main effects of drug and 
memory, and the drug x memory interaction were estimated by contrasting the relevant task 
conditions. The main effects o f memory were investigated by comparing neural responses for 
subsequent hits and subsequent misses during encoding, and hits and misses during retrieval, 
collapsed across drug conditions. The main effects of drug were investigated by comparing the 
responses for all trials vs. null events between drug conditions. In addition, conjunction analyses 
were performed that tested the global null hypothesis using the minimum T statistic as 
implemented within SPM2, to confirm the regional overlap between the main effects o f memory 
and drug (Friston, Penny, & Glaser, 2005). To assess the relation between neural activity and 
memory performance across subjects, mean activity within each significant conjunction cluster (p
< 0.001, uncorrected) was extracted (Brett et al., 2002), and the differences in activity between the 
progesterone and placebo conditions were entered in regression analyses through the origin as a 
predictor for the difference in memory performance.
RESULTS 
Serum concentrations and questionnaires
The progesterone administration increased both the serum progesterone and allopregnanolone 
concentrations (condition x time interaction; progesterone: F(2,12) = 5.8, p < 0.05, 
allopregnanolone: F(2,12) = 23.9, p < 0.001; see Table 4.1). As expected, the baseline 
concentrations were not significantly different between the progesterone and placebo sessions 
(progesterone: t(15) = 0.6, p > 0.5; allopregnanolone: t(15) = 1.6, p > 0.1). The progesterone
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administration produced serum concentrations of allopregnanolone that are similar to those 
reached during pregnancy (Luisi et al., 2000). However, progesterone had no significant effects on 
alertness (progesterone (mean ± SEM): 410.1 ± 19.3; placebo: 417.2 ± 12.9; t(15) = 0.3, p > 0.7), 
contentedness (progesterone: 271.4 ± 8.7; placebo 273.7 ± 7.2; t(15) = 0.4, p > 0.7), and calmness 
(progesterone: 108.9 ± 5.3; placebo: 115.2 ± 3.6; t(15) = 1.5, p > 0.1) as measured with the MRS 
prior to scanning, nor on state anxiety (STAI; progesterone: 32.6 ± 1.5; placebo 33.8 ± 1.0; t(15) = 
0.7, p > 0.4) after the scanning session, even though the allopregnanolone concentration after 
scanning was in the range that could induce sedation (Timby et al., 2006). Differences in behavioral 
performance and neural activations can therefore not be explained by effects of progesterone on 
anxiety or mood states.
Progesterone decreases memory performance
The participants were asked to make a gender decision during the study phase of the memory task. 
Progesterone did not significantly affect the decision accuracy or reaction times (accuracy and 
reaction times (mean ± SEM); progesterone: 93.8 ± 0.8 %, 1051 ± 61 ms; placebo: 94.3 ± 1.2 %, 
1102 ± 68 ms; both p > 0.3), again indicating that progesterone was not sedative.
Critically, progesterone decreased the recognition accuracy for faces during the test phase of 
the memory task (d’; progesterone: 0.75 ± 0.06; placebo: 0.87 ± 0.09; t(15) = 2.2, p < 0.05). The 
hit and false alarm rates during the progesterone condition were 66.1 ± 3.1 % and 38.3 ± 2.8 %, 
respectively, and 68.6 ± 2.2 % and 36.4 ± 3.6 % during the placebo condition. Reaction times 
during the test phase were fastest for hits and slowest for misses (hits < false alarms < correct 
rejections < misses; F(3,13) = 8.9, p < 0.005, all paired t-tests p < 0.005), but the reaction times 
were not significantly affected by progesterone (hits, false alarms, correct rejections, misses; 
progesterone: 1319 ± 36 ms, 1396 ± 42 ms, 1509 ± 54 ms, 1588 ± 72 ms; placebo: 1362 ± 51 ms, 
1457 ± 56 ms, 1531 ± 60 ms, 1624 ± 72 ms; Fs < 1). In summary, the behavioral results show that 
progesterone specifically decreased recognition memory accuracy, without affecting other 
behavioral measures.
Table 4.1. Serum concentrations of progesterone and allopregnanolone after the oral administration of 400 mg 
micronized progesterone (nmol/L; mean ±  SEM).
Time (min) Progesterone Allopregnanolone
0 (baseline) 1.9 ± 0.3 0.6 ± 0.1
80 (before fMRI session) 16.2 ± 7.3 23.3 ± 8.4
190 (after fMRI session) 174.2 ± 68.4 185.8 ± 26.6
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Neural mechanism of the progesterone induced memory impairment
Memory encoding
To investigate whether progesterone decreased recognition memory accuracy for faces already by 
modulating neural activity during encoding, brain regions that supported the successful encoding 
of faces were identified first. This main effect o f memory was investigated by comparing encoding 
activity o f subsequent hits and subsequent misses, and showed that the amygdala, the 
hippocampus, and the fusiform gyrus supported memory formation of faces. In addition, regions 
in the bilateral inferior temporal gyri (extending to the fusiform gyri) and left middle occipital gyrus 
showed a larger response to subsequent hits than subsequent misses (see Table 4.2).
Second, the main effect o f drug administration showed that progesterone decreased the 
response o f the amygdala and the fusiform gyrus while viewing the faces (i.e., faces vs. null events). 
In contrast, progesterone increased the response in the hippocampus (see Table 4.2). However, the 
progesterone administration did not significantly modulate the response in the primary visual 
cortex, indicating that the drug effects in the other brain regions were not due to general changes 
in the BOLD response.
Table 4.2. Cluster maxima for brain regions showing a main effect of successful memory encoding for faces (i.e., 
subsequent hits > subsequent misses), or a main effect of drug administration (i.e., progesterone vs. placebo) on the 
response to allfaces (i.e., faces vs. null events).
MNI coordinates
x y z
Cluster size t Pa
Subsequent hits > subsequent misses
R fusiform gyrus 48 -52 -16 109 5.2 < 0.001
L fusiform gyrus -42 -68 -10 30 3.7 0.017
R amygdala 24 -4 -22 19 3.5 0.013
L amygdala -24 -6 -12 4 3.0 0.042
L hippocampus -24 -34 -2 5 3.5 0.026
L middle occipital gyrus -34 -88 20 62 4.1 < 0.001b
Placebo > progesterone
R fusiform gyrus 36 -54 -14 91 4.1 0.006
L amygdala -32 -8 -18 6 3.0 0.038
Progesterone > placebo
R hippocampus 22 -28 -4 23 4.0 0.009
M N I coordinates o f  cluster maximum; Cluster size in num ber o f  significant voxels. 
a P-values are corrected for multiple comparisons across the search volume (p < 0.05). 
b P-value is uncorrected for multiple comparisons (p < 0.001, k  > 20).
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Third, a conjunction analysis was performed to confirm the spatial overlap of the main effect 
of memory and the main effect of drug. This analysis showed that the amygdala ([24 -12 -22], 
T2(45) = 2.3, p = 0.007, corrected; see Fig. 4.1A-B), the fusiform gyrus (left [-38 -70 -12], T2(45) = 
2.4, p = 0.01, corrected; right [40 -52 -16], T2(45) = 3.3, p = 0.036, whole brain corrected; see Fig. 
4.1D-E), and the middle temporal gyrus ([56 -40 -12], T2(45) = 3.7, p = 0.002, whole brain 
corrected) supported memory formation, and that progesterone decreased the response of these 
brain regions.
Fourth, to assess whether the progesterone induced decrease in activity is related to the 
decrease in memory performance across subjects, the difference in activity between the 
progesterone and placebo sessions was entered in a regression analysis as predictor for the 
difference in memory performance. The decrease in right amygdala (R2 = 0.36, p = 0.005, one­
tailed; see Fig. 4.1C) and right fusiform gyrus (R2 = 0.30, p = 0.012, one-tailed; see Fig. 4.1F) 
activity was positively related to the decrease in d’ across subjects, i.e., the extent to which 
progesterone modulates activity within these brain regions predicted the effect of progesterone on 
memory performance.
Figure 4.1. Progesterone reduced the recruitment of the amygdala and fusiform gyrus during memory encoding, brain 
regions that supported memory formation of faces. A  Significant conjunction of main effect of memory (i.e., 
subsequent hits (SH) > subsequent misses (SM)) and main effect of drug (i.e., placebo (faces > null events) > 
progesterone (faces > null events)) in the right amygdala (y = -12;p  < 0.001, uncorrected). B. Parameter estimates 
of the conjunction cluster (arbitrary units; mean ±SEM ). C. The progesterone induced decrease in amygdala activity 
predicted the decrease in memory performance across subjects (recognition memory accuray (d)). D-F. Identical 
figures for the significant conjunction of main effects in the rightfusiform gyrus (y = -52).
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Importantly, the results showed no significant drug x memory interaction. This suggests that 
progesterone did not modulate memory formation per se, as progesterone did not change the 
differential response between subsequent hits and subsequent misses.
Recognition memory
To investigate whether progesterone decreased recognition memory accuracy also by modulating 
neural activity during retrieval, brain regions that supported the successful recognition o f faces 
were identified first. The main effect of memory was investigated by comparing the recognition 
activity of hits and misses, and showed that the fusiform gyrus also supported the recognition of 
faces. In addition, regions in the caudate nuclei, bilateral inferior frontal gyri, and middle cingulate 
gyrus showed a larger response to hits than misses (see Table 4.3).
Second, as during encoding, the main effect of drug administration during recognition showed 
that progesterone decreased fusiform gyrus responses while subjects viewed faces (i.e., all faces vs. 
null events). It also decreased the response in the left inferior frontal gyrus (see Table 4.3), but did 
not significantly modulate the response in the primary visual cortex.
Table 4.3. Cluster maxima for brain regions showing a main effect of successful memory retrieval offaces (i.e., hits 
> misses), or a main effect of drug administration (i.e., progesterone vs. placebo) on the response to all faces (i.e., 
faces vs. null events).
MNI coordinates
x y z
Cluster size t pa
Hits >  misses
R fusiform gyrus 46 -56 -10 44 4.0 0.008
R /L  caudate nuclei 14 -2 16 479 4.7 < 0.001b
R inferior frontal gyrus 40 40 12 63 4.3 < 0.001b
L inferior frontal gyrus -44 30 16 37 3.7 < 0.001b
Middle cingulate cortex -4 2 34 55 3.7 < 0.001b
Placebo >  progesterone
R fusiform gyrus 42 -58 -12 330 5.1 < 0.001
L fusiform gyrus -34 -66 -12 21 3.5 0.030
L inferior frontal gyrus -56 14 14 37 3.7 < 0.001b
M N I coordinates o f  cluster maximum; Cluster size in num ber o f  significant voxels. 
a P-values are corrected for multiple comparisons across the search volume (p < 0.05). 
b P-values are uncorrected for multiple comparisons (p < 0.001, k  > 20).
50
Third, the conjunction analysis showed that the fusiform gyrus (left [-32 -64 -16], T2(45) — 2.4, 
p — 0.01, corrected; right [46 -56 -10], T2(45) — 3.7, p — 0.005, whole brain corrected, see Fig. 
4.2A-B) and the inferior frontal gyrus (p < 0.001, uncorrected, cluster > 20 voxels, see Fig. 4.2D- 
E) supported recognition memory, and that progesterone decreased the response of these brain 
regions.
Fourth, the regression analyses with the difference in activity between the progesterone and 
placebo sessions as predictor for the difference in memory performance across subjects showed 
that the decrease in right fusiform gyrus (R2 — 0.41, p — 0.003, one-tailed; see Fig. 4.2C) and left 
inferior frontal gyrus (R2 — 0.19, p — 0.04, one-tailed; see Fig. 4.2F) activity was positively related 
to the decrease in d’ across subjects. As during encoding, the extent to which progesterone 
modulated activity within these brain regions during recognition also predicted the effect of 
progesterone on memory performance.
Again, the drug x memory interaction showed no significant modulation of recognition 
processes, which suggests that progesterone did not modulate memory retrieval per se.
Figure 4.2. Progesterone reduced the recruitment of the fusiform gyrus and inferior frontal gyrus during recognition 
memory, brain regions that supported memory retrieval of faces. A  Significant conjunction of main effect of memory 
(i.e., hits (H) > misses (M)) and main effect of drug (i.e., placebo (faces > null events) > progesterone (faces > null 
events)) in the right fusiform gyrus (y = -56; p  < 0.001, uncorrected). B. Parameter estimates of the conjunction 
cluster (arbitrary units; mean ±  SEM). C. The progesterone induced decrease in fusiform gyrus activity predicted the 
decrease in memory performance across subjects (recognition memory accuray (d)). D-F. Identical figures for the 
significant conjunction of main effects in the left inferior frontal gyrus (y = 26).
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DISCUSSION
The results o f the present study demonstrate that a single progesterone administration impairs 
memory for faces by reducing the neural response in the amygdala and fusiform gyrus during 
memory encoding, and in the fusiform gyrus and prefrontal cortex during memory retrieval. 
Moreover, the progesterone induced decrease in activation predicted the decrease in memory 
performance across subjects. However, progesterone did not affect the memory processes per se, 
as progesterone did not change the differential activity between (subsequent) hits and (subsequent) 
misses. Therefore, these results suggest that progesterone impairs memory by reducing the 
recruitment of those brain regions that support memory. Hence, our data reveal a neural 
mechanism by which progesterone affects memory for biologically salient stimuli, which links the 
influence of progesterone on emotion and memory. This mechanism may contribute to changes in 
mood regulation and cognition that are observed during the menstrual cycle and pregnancy.
Animal studies suggest that the acute effects o f progesterone on memory are mediated by its 
neuroactive metabolite allopregnanolone, which potentiates the inhibitory actions of GABA 
(Majewska et al., 1986). Direct allopregnanolone administrations to rodents impair memory 
performance (Johansson et al., 2002; Ladurelle et al., 2000), and this learning impairment can be 
blocked by an allopregnanolone antagonist on the GABAA-receptor (Turkmen et al., 2004). Also 
human studies suggest that the progesterone induced impairment o f verbal recall is related to 
allopregnanolone levels (Freeman, Purdy, Coutifaris, Rickels, & Paul, 1993; Freeman, Weinstock, 
Rickels, Sondheimer, & Coutifaris, 1992). However, memory effects in those studies are potentially 
mediated by the sedative effects of allopregnanolone, as the progesterone administrations also 
increased fatigue. Our results show that the effects of progesterone and/or allopregnanolone on 
memory are not merely a consequence of its sedative effects, as progesterone did not affect 
subjective (questionnaires) or objective (reaction times) measures o f alertness.
The results of the present study suggest that progesterone impairs memory by reducing the 
recruitment o f those neural processes that support memory, without affecting those processes 
directly. This pattern of results likely reflects the specific GABAergic action o f allopregnanolone, 
and thereby the GABAergic modulation of memory formation and retrieval. Glutamate but not 
GABA turnover is crucial for memory by inducing long-term potentiation (LTP) via N-methyl-D- 
aspartate (NMDA) receptor activation (Morris, Anderson, Lynch, & Baudry, 1986). Indeed, 
NMDA-receptor antagonists impair human memory by affecting medial temporal lobe memory 
processes (Grunwald et al., 1999). In contrast, allopregnanolone reduced the response amplitude to 
all stimuli, regardless of whether the item was memorized or retrieved successfully. Because the 
activation in BOLD fMRI mainly reflects excitatory neurotransmission (Waldvogel et al., 2000), 
these results suggest that allopregnanolone impairs memory via a GABAergic mechanism by 
increasing the threshold of excitatory neurons to initiate LTP. This is likely mediated by 
allopregnanolone’s modulation of extrasynaptic 8-subunit containing GABAA-receptors, which 
enhances tonic inhibition and thereby decreases neuronal excitability (Stell, Brickley, Tang, Farrant,
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& Mody, 2003). By increasing the threshold, allopregnanolone would reduce the probability that 
LTP is initiated. This suggests that allopregnanolone impairs memory by reducing the probability 
of successful memory encoding.
A similar spatial overlap of two main effects without an interaction have been observed for 
memory formation and divided attention (Uncapher & Rugg, 2005). Divided attention also impairs 
memory by reducing the probability of engaging encoding processes that support later episodic 
retrieval. However, divided attention also decreased the encoding efficiency in that study, as it 
decreased the encoding accuracy and increased reaction times. This is clearly different from the 
memory impairing effects of progesterone, since our results show no evidence of decreases in 
processing efficiency. It is therefore unlikely that our results reflect a progesterone induced 
modulation of attention. This discrepancy with the effect o f divided attention suggests that our 
results rather reflect a specific effect of progesterone on brain regions identified here as relevant 
for memory formation and retrieval.
The results suggest that progesterone impairs memory for faces by decreasing amygdala 
activity during memory encoding, as the amygdala supported memory formation in this study. The 
amygdala is essentially involved in the enhancement of memory for various emotional stimuli 
(Cahill et al., 1995; Richardson et al., 2004; Strange & Dolan, 2004), which suggests that the 
amygdala may also mediate progesterone’s effect on memory for other emotional stimuli. The 
memory enhancement for emotional stimuli is determined by the degree to which arousal activates 
the amygdala during encoding (Cahill et al., 1996; Canli et al., 2000). The progesterone induced 
decrease in amygdala response as observed here might thus be associated with the anxiolytic 
effects of allopregnanolone (Akwa et al., 1999; Bitran et al., 1995). These results therefore suggest 
that progesterone may impair memory by decreasing arousal.
Progesterone also decreased the neural response in the fusiform gyrus. This brain region is 
preferentially involved in the processing of faces (Kanwisher et al., 1997; Tsao et al., 2006), and 
face memory traces are potentially stored in this brain region (Ishai, Ungerleider, & Haxby, 2000; 
Miyashita, 1993). These results therefore suggest that progesterone impairs memory for faces by 
reducing the neural response in the fusiform gyrus, which is a potential consequence of 
progesterone’s modulation of amygdala activity during memory encoding. The amygdala influences 
emotional memory by modulating memory consolidation in other brain regions (Kilpatrick & 
Cahill, 2003; McGaugh, 2004; Packard, Cahill, & McGaugh, 1994; Richardson et al., 2004), and 
projects back to all levels o f the ventral visual stream (Amaral et al., 2003). Importantly, it 
modulates activity in the fusiform gyrus during face perception (Vuilleumier et al., 2004). 
Therefore, the progesterone induced decrease in fusiform gyrus activity may result from a decrease 
in modulatory influences from the amygdala. This study can not clarify whether progesterone has 
an indirect effect via the amygdala or a direct effect on the fusiform gyrus, but progesterone 
reduced functional coupling o f the amygdala with the fusiform gyrus in a blocked-design with 
faces as stimuli (van Wingen et al., 2008). Those results suggest that progesterone’s modulation of 
amygdala activity influences fusiform gyrus activity, but the correlational analysis used precluded a 
directional interpretation. However, animal studies using amygdala lesion and drug infusion
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methods suggest that benzodiazepines induce their amnesic effects by decreasing (basolateral) 
amygdala activity (Brioni et al., 1989; Tomaz et al., 1992), likely by decreasing norepinephrine 
turnover within the amygdala (Hatfield, Spanis, & McGaugh, 1999). We therefore suggest that 
progesterone impairs memory by its conversion to allopregnanolone, thereby decreasing amygdala 
activity and its modulatory influence, which in turn down-regulates memory encoding and 
consolidation in the fusiform gyrus.
Also the reduced neural responses in the inferior frontal gyrus could contribute to the reduced 
fusiform gyrus responses during memory retrieval. The prefrontal cortex exerts executive control 
during the active retrieval of memory representations in the inferior temporal cortex (Miyashita, 
2004; Tomita et al., 1999). The reduced prefrontal activity may therefore reflect a progesterone 
induced reduction of strategic retrieval attempts. The reduction in active top-down signaling from 
the prefrontal cortex may subsequently reduce neural activity in the fusiform gyrus due to a 
reduction in search attempts.
Other human imaging studies suggest that interactions between the amygdala and the anterior 
hippocampus are crucial for emotional memory formation (Dolcos, LaBar, & Cabeza, 2004; 
Richardson et al., 2004). However, the results o f the present study show that progesterone even 
increased posterior hippocampal activity while memory performance decreased. This discrepancy 
may be explained by the dissociation within the medial temporal lobe, as the anterior but not 
posterior medial temporal lobe supports emotional memory formation (Dolcos et al., 2004). The 
progesterone induced hippocampal activity increase may reflect the recruitment of a compensatory 
neural mechanism in an attempt to maintain adequate memory performance (Voermans et al.,
2004).
Previous studies have shown that progesterone and the hormonal changes during the 
menstrual cycle influence amygdala activity (Dreher et al., 2007; Goldstein et al., 2005; van Wingen 
et al., 2008). Whereas progesterone decreased amygdala responses in the present study, 
progesterone can also increase amygdala activity (van Wingen et al., 2008). Although this apparent 
discrepancy could be due to differences in the experimental paradigms employed, recent studies 
suggest that it is more likely explained by differences in allopregnanolone concentration. Whereas 
allopregnanolone usually decreases anxiety in animal studies (Bitran et al., 1991; Wieland et al., 
1991), moderate concentrations can increase aggressive behavior (Fish et al., 2001). Moreover, 
women that reach moderate allopregnanolone concentrations during hormonal replacement 
therapy develop negative mood symptoms more often than women reaching lower and higher 
concentrations (Andreen et al., 2006). The paradoxical amygdala activity increase in a previous 
study was observed after progesterone levels had increased from the follicular to the luteal phase 
range (van Wingen et al., 2008), whereas progesterone levels increased to levels that are reached 
during pregnancy in the present study (Luisi et al., 2000). This suggests that allopregnanolone may 
modulate amygdala activity in a nonlinear dose-dependent manner, increasing amygdala activity at 
moderate concentrations, while decreasing amygdala activity at higher concentrations.
Allopregnanolone’s modulation of amygdala activity may influence anxiety. Indeed, animal 
studies have shown that intra-amygdala infusions of allopregnanolone decreases anxiety (Akwa et
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al., 1999). Furthermore, inhibiting progesterone’s metabolization to allopregnanolone within the 
amygdala increases anxiety (Walf, Sumida, & Frye, 2006). However, a recent study indicates that 
allopregnanolone may modulate anxiety by modulation of the bed nucleus of the stria terminalis 
(BNST) rather than the amygdala. In that study, allopregnanolone attenuated corticotropin- 
releasing factor (CRF)-enhanced startle but not fear-potentiated startle (Toufexis, Davis, 
Hammond, & Davis, 2004). Previous studies have shown that CRF-enhanced startle is mediated by 
the BNST, whereas the amygdala mediates fear-potentiated startle. Consequently, the BNST has 
been proposed to support longer-lasting anxiety, and the amygdala to support stimulus-specific 
fear (Walker, Toufexis, & Davis, 2003). In the present study, progesterone reduced amygdala 
responses to specific stimuli (i.e., faces). Although our study does not exclude an effect on the 
BNST, allopregnanolone’s modulation o f the amygdala may specifically influence fear (Walker et 
al., 2003), and/or modulate more generalized anxiety as suggested by other studies (Akwa et al., 
1999; Walf et al., 2006).
In conclusion, we have used a placebo-controlled progesterone administration to healthy 
young women in combination with event-related fMRI, to provide a mechanistic account for the 
memory impairing effects o f progesterone. Our results reveal that progesterone impairs memory 
for faces by reducing neural responses in the amygdala and fusiform gyrus during encoding, and in 
the fusiform gyrus and prefrontal cortex during retrieval. The progesterone induced decrease in 
activation predicted the decrease in memory performance across subjects. However, progesterone 
did not modulate the differential activation between (subsequently) remembered and 
(subsequently) forgotten faces. This pattern of results therefore suggests that progesterone impairs 
memory by reducing the recruitment of those brain regions that support memory. These 
mnemonic effects o f progesterone are likely mediated by its neuroactive metabolite 
allopregnanolone. Furthermore, given the important role of the amygdala in the modulation of 
memory, these results suggest that allopregnanolone alters memory by influencing amygdala 
activity, which in turn may affect memory processes in other brain regions. These findings reveal a 
neural mechanism by which progesterone influences emotion and memory, which may contribute 
to changes in mood regulation and cognition that are observed during the menstrual cycle and 
pregnancy.
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ABSTRACT
Testosterone modulates mood and sexual function in women. However, androgen levels decline 
with age, which may relate to the age-associated change in sexual functioning and the prevalence of 
mood and anxiety disorders. These effects of testosterone are potentially mediated by the 
amygdala. In the present study, we investigated whether the age related decline in androgen levels 
is associated with reduced amygdala activity, and whether exogenous testosterone can restore 
amygdala activity. Healthy young and middle-aged women participated during the early follicular 
phase of the menstrual cycle, and amygdala responses to biologically salient stimuli were measured 
with functional magnetic resonance imaging (fMRI). Androgen levels were lower in middle-aged 
than young women, which was associated with decreased amygdala reactivity. Endogenous 
testosterone levels correlated positively with amygdala reactivity across the young and middle-aged 
women. The middle-aged women received a single nasal dose of testosterone in a double-blind, 
placebo-controlled, crossover manner, which rapidly increased amygdala reactivity to a level 
comparable to the young women. The enhanced testosterone levels correlated positively with 
superior frontal cortex responses and negatively with orbitofrontal cortex responses across 
individuals, which may reflect testosterone induced changes in amygdala regulation. These results 
show that testosterone modulates amygdala reactivity in women, and suggest that the age related 
decline in androgen levels contribute to the decrease in amygdala reactivity.
57
INTRODUCTION
Androgen levels in women decline with age, such that a women has about half her early adulthood 
levels at age forty (Davison, Bell, Donath, Montalto, & Davis, 2005; Zumoff et al., 1995). 
Synchronously with the age related decline in androgen levels, the prevalence o f affective and 
anxiety disorders decreases (Henderson et al., 1998; Kessler et al., 2003; Kessler et al., 1994). 
However, sexual functioning also declines in women (Hayes & Dennerstein, 2005; Hayes et al., 
2007). Thus, the change in androgen levels might contribute to both the susceptibility for mood 
disorders and for sexual dysfunction. For example, the decrease in gonadal steroid hormone 
concentrations after oophorectomy is associated with a worsening of mood and sexual motivation, 
which improves with subsequent testosterone treatment (Sherwin & Gelfand, 1985; Sherwin, 
Gelfand, & Brender, 1985; Shifren et al., 2000). In addition, testosterone treatment also improves 
well-being, mood, and sexual function in healthy premenopausal women with low libido (Goldstat, 
Briganti, Tran, Wolfe, & Davis, 2003). However, it remains unknown by which neural mechanism 
testosterone influences mood and sexual function, and whether this is related to the age related 
decline in androgen levels.
Animal studies suggest that testosterone influences mood and sexual function by modulating 
amygdala activity, a brain structure implicated in mood and anxiety regulation (Drevets, 2003; 
Rauch et al., 2003) as well as sexual arousal (Gizewski et al., 2006; Hamann, Herman, Nolan, & 
Wallen, 2004; Karama et al., 2002). Testosterone modulates functioning o f amygdala neurons in 
male and female rodents (Kendrick, 1981; Kendrick & Drewett, 1979), and testosterone infusions 
into the amygdala increase sexual behavior in male rodents (Bialy & Sachs, 2002; Wood & 
Newman, 1995). Whereas these studies investigated the effects of prolonged testosterone 
exposure, recent studies suggested that testosterone influences anxiety and sexual behavior also 
rapidly (Aikey, Nyby, Anmuth, & James, 2002; James & Nyby, 2002). Moreover, a single 
testosterone administration already increases physiological arousal in response to affective and 
erotic stimuli in women (Tuiten et al., 2000; van Honk et al., 2001).
The present study investigated whether nasally applied testosterone rapidly increases amygdala 
reactivity in healthy, naturally cycling, middle-aged women, using a double-blind, placebo­
controlled, crossover design. Amygdala reactivity to biologically salient stimuli was measured with 
functional magnetic resonance imaging (fMRI). To investigate whether the diminished endogenous 
levels o f androgens during middle adulthood influence amygdala activity, the placebo session was 
compared with the placebo session of young, healthy, naturally cycling women, who participated in 
an identical experiment with a different drug manipulation (van Wingen et al., 2008) and who were 
expected to have higher androgen levels.
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MATERIALS AND METHODS 
Participants
This study included two groups of participants. The experimental group consisted o f 27 middle- 
aged, naturally cycling, premenopausal women. One participant was not available for the second 
study occasion, and data of one session of another subject were lost due to a technical failure. 
Therefore, the results are based on the data of the remaining twenty-five participants (mean age 42 
years; range: 37-50 years). The reference group consisted of seventeen young, naturally cycling 
women (mean age 23 years; range: 19-30) who participated previously in another study with the 
same experimental procedure but a different drug manipulation (van Wingen et al., 2008). All 44 
participants were physically and mentally healthy as determined by a structured interview, were free 
of medication and hormonal contraceptives, and right handed. The study was approved by the 
local ethics committee (CMO Regio Arnhem-Nijmegen, The Netherlands). All participants gave 
written informed consent after the study had been explained to them.
Design and procedure
All women participated twice during the early follicular phase (day 1-7) o f different menstrual 
cycles, to ensure low endogenous hormone levels. The middle-aged women first completed a 
sexual arousal questionnaire (SAQ) (Tuiten et al., 2000), before the first venous blood sample was 
collected. Thereafter, a nasal dose of testosterone (0.9 mg; Noseafix®) or placebo was administered 
in a double-blind, crossover manner. Prior to scanning (30 min after drug intake), they completed 
the SAQ again and a second blood sample was drawn. About 140 min after drug intake, the final 
SAQ was administered, after which the participants completed mood (Mood Rating Scale; MRS) 
(Bond & Lader, 1974) and state anxiety (State Trait Anxiety Inventory; STAI) (Spielberger et al., 
1970) questionnaires. The young women of the reference group completed a similar procedure, 
described in van Wingen and others (2008).
Behavioral task
The experimental paradigm consisted of a blocked design, including an emotion condition and a 
visuo-motor control condition. This paradigm has been used previously to investigate drug effects 
on amygdala reactivity (Hariri et al., 2002a; Paulus et al., 2005; van Wingen et al., 2008). It robustly 
engages the amygdala, by contrasting the response to simultaneously presented angry and fearful 
face stimuli (http://www.macbrain.org) with the response to ellipses (that consisted of scrambles 
of the same face stimuli). The results therefore do not show emotion specific effects, but rather a 
general response to salient, biologically relevant stimuli.
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Two emotion blocks were interleaved with three control blocks, and each 30 s block consisted 
of six 5 s trials. Each trial consisted o f three simultaneously presented stimuli, with the cue 
stimulus presented above the target and distractor. In the emotion condition, an angry or fearful 
face was presented on top as cue, and subjects had to indicate by an appropriate button press 
which o f the bottom two faces (one angry and one fearful) matched the cue in emotional 
expression. The three simultaneously presented faces per trial were from different persons from 
the same sex. Half the trials presented faces of men and half o f women, half o f each target 
emotion (angry or fearful). In the control condition, a horizontally or vertically oriented ellipse was 
presented as cue above two ellipses (one vertical and one horizontal), and subjects had to select the 
identically oriented ellipse.
MRI data acquisition
MR data were acquired with a 1.5 T Siemens Sonata MR scanner (Siemens, Erlangen, Germany), 
equipped with a standard head coil. Seventy-six T2*-weighted blood oxygenation level-dependent 
(BOLD) images were acquired using echo-planar imaging (EPI) with an echo time o f 30 ms to 
reduce signal dropout, with each image volume consisting o f 33 axial slices (3 mm, 0.5 mm slice­
gap, TR = 2.290 s, 64 x 64 matrix, FOV = 224 mm, FA = 90°). In addition, a high resolution T1- 
weighted structural MR image was acquired for spatial normalization procedures (3D MP-RAGE, 
TR = 2250 ms, TE = 3.93 ms, TI = 850 ms, 176 contiguous 1 mm slices, 256 x 256 matrix, FOV 
= 256 mm).
FMRI data analysis
Image analysis was performed with SPM2 (Wellcome Department of Imaging Neuroscience, 
London, UK). The first five EPI-volumes were discarded to allow for T1 equilibration, and the 
remaining images were realigned to the first volume. Images were then corrected for differences in 
slice acquisition time, spatially normalized to the Montreal Neurological Institute T1 template, 
super-sampled into 2 x 2 x 2 mm3 voxels, and spatially smoothed with a Gaussian kernel of 10 
mm FWHM.
Statistical analysis was performed within the framework of the general linear model (Friston et 
al., 1995). For each drug condition, the two experimental conditions were modeled as box-car 
regressors convolved with the canonical hemodynamic response function of SPM2. In addition, 
the realignment parameters were included to model potential movement artifacts as well as a high­
pass filter (cut-off at 1/128 Hz). In order to account for various global effects, the EPI-data was 
proportionally scaled. Temporal autocorrelation was modeled with an AR(1) process and the 
parameter estimates were obtained by maximum likelihood estimation (Friston et al., 2002) to 
allow departures from sphericity. Parameter images contrasting the emotion and visuo-motor 
control condition were obtained, and analyzed in subsequent random-effects analyses. Drug effects 
were assessed with paired t-tests, and independent samples t-tests were used to identify age effects.
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Statistical tests were family-wise error rate corrected for multiple comparisons across the whole 
brain. A small volume correction (Worsley et al., 1996) was used to correct for multiple 
comparisons across the search volume for regions of interest. As the basolateral amygdala is 
critically involved in sexual motivation (Everitt, 1990), the search volume for the amygdala was 
defined as a sphere with 7 mm radius around the probabilistic cytoarchitectonic center o f the 
basolateral amygdala ([-26 -8 -18] and [28 -8 -18]), which approximates total amygdala volume 
(Amunts et al., 2005; Eickhoff et al., 2005). In addition, the face responsive region in the fusiform 
gyrus was defined as a sphere with 10 mm radius around previously reported Talairach coordinates 
(Kanwisher et al., 1997), that were transformed into MNI-space (http://imaging.mrc- 
cbu.cam.ac.uk/imaging/MniTalairach; [-36 -64 -16] and [40 -56 -16]). The inverse transformation 
was used to convert the results from MNI to Talairach space, and all local activation maxima are 
reported in Talairach coordinates. In addition, region-of-interest (ROI) analyses were conducted to 
compare amygdala reactivity across the different conditions, for which the mean activity within 
amygdala search volumes was extracted (Brett et al., 2002). Effect sizes for these ROI analyses 
were calculated, and r = 0.10 indicates a small effect, r = 0.30 a medium effect, and r = 0.50 a large 
effect (Cohen, 1992).
Serum analysis
The serum concentrations of total testosterone (T) were measured by liquid chromatography with 
tandem mass spectrometry detection after non-polar solvent extraction. Serum concentrations of 
dehydroepiandrosterone sulfate (DHEA-S), dihydrotestosterone (DHT), and 3a-androstanediol 
glucuronide (3a-diol) were measured by radioimmunoassay (RIA). The coefficients of variation for 
T were 4.3-14.8 % for the inter-assay and 0.7-17.3 % for the intra-assay precision, for DHEA-S 
6.5-8.4 % for the inter-assay and 3.6-6.9 % for the intra-assay precision, for DHT 6.2-11.9 % for 
the inter-assay and 2.2-18.1 % for the intra-assay precision, and for 3a-diol 11-24 % for the inter­
assay and 8.0-23 % for the intra-assay precision.
RESULTS 
Age effects on androgen levels and amygdala reactivity
Serum concentrations, questionnaire, and behavioral performance
Baseline serum concentrations o f dehydroepiandrosterone sulfate (DHEA-S; t(40) = 4.6, p < 
0.001), testosterone (T; t(40) = 5.0, p < 0.001), dihydrotestosterone (DHT; t(19.7) = 7.3, p < 
0.001), and 3a-androstanediol glucuronide (3a-diol; t(26.1) = 4.1, p < 0.001) were significantly 
lower in middle-aged than young women, but sex hormone binding globulin (SHBG), and albumin
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(both p > 0.15) levels were not significantly different between the age groups (see Table 5.1). The 
age groups did not significantly differ in state anxiety as measured with the STAI after scanning 
(mean ± SEM; young: 35.5 ± 2.0; middle-aged: 33.1 ± 1.6; p > 0.3), but the younger women were 
more accurate in matching the stimuli in both experimental conditions (emotion and control 
condition) than the middle-aged women (young: 98.2 ± 0.9 % correct, middle-aged: 91.5 ± 1.8 % 
correct; F(1,35) = 8.7, p = 0.006). In addition, the young women were faster than the middle-aged 
women in all responses (young: 1460 ± 59 ms, middle-aged: 1748 ± 92 ms; F(1,35) = 5.6, p = 
0.024), but no significant group x task condition interactions were observed.
Imaging results
In the young women, the emotion condition yielded larger responses than the visuo-motor control 
condition in the amygdala, ventral visual stream (ranging from the primary visual cortex to the 
fusiform gyrus), middle temporal gyrus, inferior prefrontal gyrus, midbrain, supplementary motor 
area, premotor cortex, and occipital gyrus (see Fig. 5.1A and Table 5.2). In the middle-aged 
women, the ventral visual stream, inferior prefrontal gyrus, and supplementary motor area were 
also significantly activated. In addition, the neural response in the temporal pole was larger during 
the emotion than control condition, but no significant activation was observed in the amygdala 
(see Fig. 5.1B and Table 5.2). After lowering the statistical threshold, a non-significant activation 
within the amygdala was observed (peak voxel: [-20 -6 -13], t(24) = 2.6, p = 0.008, uncorrected), 
potentially indicating a weak or variable amygdala response.
Comparing neural responses between the young and middle-aged women revealed that 
amygdala reactivity was larger in the young than middle-aged women. In addition, the neural 
response to emotional faces was larger in the young than middle-aged women in the ventral visual 
stream ranging from the extra-striate visual cortex to the fusiform gyrus. Conversely, the neural 
response to emotional faces was larger in the middle-aged than young women in the superior 
temporal gyrus, superior frontal gyrus, anterior cingulate cortex, superior frontal gyrus, middle 
frontal gyrus, and operculum (see Table 5.3). After correction for task difficulty by including 
reaction times as covariate, the bilateral superior frontal gyri and right superior temporal gyrus 
responses remained significantly larger in the middle-aged than young women. Importantly, the 
pattern of results with significantly larger amygdala and ventral visual stream responses in the 
young than middle-aged women remained virtually identical. The differences in amygdala and 
superior frontal activity between the groups are therefore not related to differences in task 
performance.
To investigate whether these age differences in neural responses could by explained by 
differences in endogenous testosterone levels, a correlation analysis was performed. The 
testosterone levels of the young and middle-aged women during the placebo sessions were 
positively correlated with neural responses in the amygdala, fusiform gyrus, and insula across 
individuals (see Fig. 5.2 and Table 5.4). Neural responses in the posterior cingulate cortex and 
superior frontal gyrus correlated negatively with testosterone levels (see Table 5.4). Although these
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correlations indicate that age differences in amygdala reactivity could be mediated by differences in 
testosterone levels, these associations are inherently confounded by age effects as testosterone 
levels were highly correlated with age (r(42) = -0.53, p < 0.001). Inclusion of age as covariate did 
not alter the pattern of results in the amygdala and fusiform gyrus, but these positive correlations 
did not remain significant after correction for multiple comparisons. To investigate whether 
testosterone indeed mediates amygdala reactivity, a crossover placebo-controlled design was used.
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Figure 5.1. Amygdala reactivity to biologically salient stimuli in young and middle-aged women. A . Significant 
amygdala activity in the placebo condition of young women (N  = 17). B. No significant amygdala activity in the 
placebo condition of middle-aged women (N  = 25). C. Significant amygdala activity in middle-aged women after a 
single nasal administration of testosterone (N  = 25). A ll figures show coronal, sagittal, and axial planes at the 
amygdala peak ([-22 -8 -11]) at a statistical threshold of p  < 0.001, uncorrected, cluster > 20 voxels (T(16) > 
3.69 in panel A ; T(24) >3.47 in panels B and C).
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Figure 5.2. Baseline serum testosterone level correlates positively with amygdala (A; y  = -3) and fusiform gyrus (B; 
y  = -58) activity across young (circles) and middle-aged (triangles) women in the placebo sessions. Left figures show 
coronal planes (left = left) at the cluster maxima at a statistical threshold of p  < 0.005, uncorrected, for illustration.
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Table 5.1. Baseline serum concentrations in young (N  — 17) and middle-aged (N  — 25) women in the placebo conditions, and serum 
concentrations in the testosterone condition before and 30 min after a nasal testosterone dose.
Young women Middle-aged women
Placebo Placebo Testosterone
Baseline Baseline Baseline 30 min
Mean SEM Mean SEM Mean SEM Mean SEM
3a-diol (pmol/L) 6183.7 727.8 2774.8 412.0 2732.1 354.0 2736.4 352.3
Albumin (g/L) 43.1 0.9 42.4 0.6 42.3 0.5 - -
DHEA-S (nmol/L) 5847.1 536.9 3169.5 307.3 3173.9 311.9 - -
DHT (pmol/L) 605.1 41.7 265.2 20.9 279.8 36.9 367.9 40.1
Estradiol (pmol/L) - - 186.5 33.2 144.8 18.3 146.4 18.9
SHBG (nmol/L) 79.1 6.4 100.0 11.9 95.8 8.3 - -
Testosterone (pmol/L) 964.8 58.3 637.2 37.5 672.7 52.7 3398.1 404.5
Abbreviations: 3(X-diol, 3a-androstanediol glucuronide; DHEA-S, dehydroepiandrosterone sulfate; DHT, dihydrotestosterone; 
SHBG, sex hormone binding globulin.
Table 5.2. Main effects of task for the young (N  = 17) and middle-aged (N  = 25) women in the placebo condition, 
and for middle-aged women after a single nasal testosterone dose (i.e., matching angry and fearfulfaces > matching 
scrambled face stimuli).
x y z Cluster size Z
Young women: Placebo condition
R inferior occipitotemporal cortex 28 -88 -2 4096 6.1
L inferior occipitotemporal cortex -12 -95 -5 4186 6.0
L amygdala -22 -8 -11 281 5.1
R amygdala 22 -8 -11 150 4.8
R middle temporal gyrus 46 -56 16 78 4.6
L inferior frontal gyrus -42 9 27 532 4.5
R inferior frontal gyrus 44 11 27 721 4.3
Midbrain 4 -35 2 157 4.3
Supplementary motor area -2 11 35 208 4.2
R premotor cortex 42 2 44 84 4.1
R occipital gyrus 38 -69 24 31 3.6
Middle-aged women: Placebo condition
L inferior occipitotemporal cortex -26 -93 1 2262 6.3
R inferior occipitotemporal cortex 22 -95 -2 2638 6.3
R inferior frontal gyrus 48 22 21 501 5.1
L inferior frontal gyrus -53 17 27 263 4.7
Supplementary motor area 2 12 47 368 4.6
L temporal pole -30 5 -19 49 3.9
Middle-aged women: Testosterone condition
L /R  inferior occipitotemporal cortex 18 -89 1 7642 6.3
R inferior frontal gyrus 48 9 33 1543 5.5
L inferior frontal gyrus -38 11 27 851 4.7
L amygdala -22 -8 -11 224 4.6
L orbitofrontal cortex -48 23 -13 40 4.3
Medial superior frontal gyrus 4 27 39 124 4.1
Precuneus 0 -58 49 50 3.9
R hippocampus 22 -22 -6 49 3.9
R amygdala 20 -6 -11 56 3.5
D ata are Talairach coordinates for cluster maxima at p < 0.001 with a cluster size > 20 voxels; Cluster size in
num ber o f  significant voxels.
Table 5.3. Effects of age on emotion processing during the placebo conditions (i.e., age x  task interaction).
x y z Cluster size Z SVC p
Young > middle-aged women
R inferior occipital cortex 32 -81 6 568 4.6
L inferior occipitotemporal cortex -22 -83 4 753 4.5
L fusiform gyrusa -42 -57 -7 61 4.3 0.001
R fusiform gyrusa 36 -57 -6 73 3.8 0.006
L amygdala* -24 -6 -13 46 3.7 0.004
L lingual gyrus -22 -58 0 47 3.5
R amygdala“ 28 -12 -11 1 3.2 0.017
Middle-aged > young women
R superior temporal gyrus 67 -19 12 82 4.4
L superior frontal gyrus -24 41 37 63 4.0
Anterior cingulate cortex -6 31 0 73 3.9
R superior frontal gyrus 16 20 48 158 3.9
R middle frontal gyrus 28 56 -1 20 3.7
L operculum -65 -26 25 25 3.5
D ata are Talairach coordinates for cluster maxima at p < 0.001 with a cluster size > 20 voxels; Cluster size in 
num ber o f  voxels (p < 0.001, uncorrected); SVC p is small volume corrected p value. 
a D ata from  the search volume o f  the region-of-interest.
Table 5.4. Correlation analysis between testosterone levels and neural responses to emotional faces (i.e., matching 
angry and fearful faces > matching scrambled face stimuli) in the placebo session of the young and middle-aged 
women.
x y z Cluster size Z SVC p
Positive correlation
L insula -40 -14 -6 53 3.8
R fusiform gyrusa 32 -55 -6 26 3.2 0.041
L amygdalaa -24 -3 -13 1 3.3 0.015
Negative correlation
Posterior cingulate cortex -8 -33 35 145 3.8
R superior frontal gyrus 24 31 43 32 3.4
D ata are Talairach coordinates for cluster maxima at p < 0.001 with a cluster size > 20 voxels; Cluster size in 
num ber o f  voxels (p < 0.001, uncorrected); SVC p is small volume corrected p value. 
a D ata from  the search volume o f  the region-of-interest.
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Rapid effects of testosterone on androgen levels and amygdala reactivity in middle-aged 
women
Serum concentrations, questionnaires, and behavioral performance
No significant differences were observed in all serum measures o f the baseline samples o f the two 
study days (i.e., T, DHT, 3a-diol, DHEA-S, estradiol, progesterone, luteinizing hormone, SHBG, 
and albumin; all paired t-tests p > 0.2). The nasal testosterone dose increased the T (drug x time 
interactions: F(1,24) = 48.1, p < 0.001) and DHT (F(1,23) = 10.8, p = 0.003) concentrations at 30 
minutes after administration, but the 3a-diol (p > 0.15) and estradiol (p > 0.3) levels were not 
significantly increased (see Table 5.1). The testosterone level that was reached is within the upper 
range for healthy women (Davison et al., 2005; Zumoff et al., 1995). Testosterone did not 
influence sexual lust, bodily arousal, and genital arousal as measured with the SAQ (drug x time 
interactions; p > 0.2), state anxiety as measured with the STAI (mean ± SEM; placebo: 33.1 ± 1.6; 
testosterone: 33.1 ± 1.9; p > 0.9), and alertness (placebo: 322.4 ± 22.6; testosterone: 315.8 ± 25.6; p 
> 0.8), contentedness (placebo: 240.3 ± 9.9; testosterone: 247.0 ± 10.4; p > 0.6), and calmness 
(placebo: 110.7 ± 5.0; testosterone: 111.5 ± 6.9; p > 0.9) as measured with the MRS. In addition, 
testosterone did not significantly modulate response accuracy (percentage correct; placebo: 
emotion condition 89.8 ± 2.4 %, control condition 93.2 ± 1.8 %; testosterone: emotion condition 
91.0 ± 2.8 %, control condition 96.0 ± 1.6 %; p > 0.4) or reaction times (placebo: emotion 
condition 2237 ± 102 ms, control condition 1260 ± 103 ms; testosterone: emotion condition 2205 
± 102 ms, control condition 1245 ± 113 ms; p > 0.7) during the behavioral task. These results 
indicate that the testosterone induced differences in neural responses are unlikely explained by 
changes in mood states or behavioral performance.
Imaging results
In the testosterone session of the middle-aged women, the emotion condition yielded larger 
responses than the visuo-motor control condition in the ventral visual stream (ranging from the 
primary visual cortex to the fusiform gyrus), inferior frontal gyrus, orbitofrontal cortex, medial 
superior frontal gyrus, precuneus, and hippocampus. Importantly, significant bilateral amygdala 
activity was observed (see Fig. 5.1C and Table 5.2). Direct comparisons showed that testosterone 
increased left amygdala reactivity in the middle-aged women (see Table 5.5). A similar effect was 
also observed in the right amygdala, although at a less conservative statistical threshold ([24 -12 - 
13], t(24) = 2.6, p = 0.008, uncorrected). In addition, testosterone increased the neural response to 
emotional faces in the inferior frontal and middle temporal gyri. Conversely, testosterone reduced 
the neural response to emotional faces in the precuneus (see Table 5.5).
A correlation analysis was performed to identify whether the enhanced testosterone levels 
were related to neural responses across individuals. Testosterone levels correlated positively with
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neural responses in the middle frontal gyrus (BA 9), superior frontal gyrus, supramarginal gyrus, 
and precuneus. Testosterone levels correlated negatively with responses in the orbitofrontal cortex 
(BA 47) and occipital gyrus (see Table 5.5 and Fig. 5.3). Although testosterone reliably increased 
amygdala reactivity within subjects, no significant correlations with amygdala reactivity were 
observed across individuals, indicating individual differences in sensitivity to high testosterone 
levels.
To investigate whether testosterone increased amygdala reactivity of the middle-aged women 
to a level comparable to the young women, the data from the amygdala ROIs were extracted and 
averaged. The ROI analyses confirmed that amygdala reactivity was higher in the young than 
middle-aged women (left: t(40) = 3.1, p = 0.004, effect size: r = 0.44; right: t(40) = 2.1, p = 0.043, r 
= 0.31), and that testosterone increased left amygdala reactivity in the middle-aged women (left: 
t(24) = 2.2, p = 0.035, r = 0.41; right: t(24) = 1.3, p = 0.19, NS, r = 0.27). Importantly, 
testosterone increased amygdala reactivity in middle-aged women to a level comparable to that of 
young women (left: t(40) = 1.2, p = 0.25, NS, r = 0.18; right: t(40) = 1.1, p = 0.26, NS, r = 0.18; 
see Fig. 5.4).
Table 5.5. Effects of a single nasal testosterone administration on emotion processing in middle-aged women (i.e., 
drug x  task interaction), and correlations with serum testosterone levels in the testosterone condition across 
participants.
x y z Cluster size Z SVC p
Testosterone > placebo
L amygdala* -30 -12 -11 18 4.2 0.001
R inferior frontal gyrus 52 27 5 55 4.0
L middle temporal gyrus -48 0 -14 88 3.6
R amygdala“ 24 -12 -13 - 2.4 0.109
Placebo > testosterone
Precuneus -10 -32
Testosterone condition: Positive correlation with testosterone level
50 22 3.4
L middle frontal gyrus -30 21 30 86 4.6
R superior frontal gyrus 12 33 48 31 3.8
L supramarginal gyrus -50 -49 28 80 3.8
R precuneus 8 -60
Testosterone condition: Negative correlation with testosterone level
42 25 3.4
R occipital gyrus 10 -91 -10 34 3.7
R orbitofrontal cortex 28 22 -22 27 3.5
L orbitofrontal cortex -27 19 -17 46 3.5
D ata are Talairach coordinates for cluster maxima at p < 0.001 with a cluster size > 20 voxels; Cluster size in 
num ber o f  voxels (p < 0.001, uncorrected); SVC p is small volume corrected p value. 
a D ata from  the search volume o f  the region-of-interest.
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Figure 5.3. Serum testosterone level after a single nasal testosterone dose correlates positively with left dorsolateral 
prefrontal cortex (A; DLPFC, BA  9,y  = 21) and negatively with orbitofrontal cortex (B; OFC, BA  47,y  = 
22) activity across middle-aged women. Left figures show coronal planes (left = left) at the cluster maxima at a 
statistical threshold of p  < 0.001, uncorrected, cluster >20 voxels.
Figure 5.4. Testosterone increases amygdala reactivity to biologically salient stimuli in middle-aged women (N  — 25) 
to a level comparable to young women (N  — 17). The figure shows the mean (±SEM ) amygdala response averaged 
across the amygdala region-of-interest. **p  < 0.01, *p  < 0.05.
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DISCUSSION
The present study investigated whether androgens influence amygdala reactivity in healthy, 
naturally cycling women. The results show that the age related decline in androgen levels is 
associated with a decrease in amygdala reactivity. A double-blind, placebo-controlled, crossover 
study was applied to investigate whether exogenous testosterone modulates amygdala reactivity in 
premenopausal middle-aged women, who have about half their early adulthood androgen levels. 
The results show that a single nasal testosterone administration rapidly (within 45 min) increases 
amygdala reactivity in the middle-aged women to a young adulthood level.
The amygdala is part of a larger emotion circuitry, which is important for the identification of 
the emotional significance of stimuli, the generation of an affective response, and emotion 
regulation (Phillips et al., 2003a). The endogenous testosterone levels were positively related to 
neural responses in the fusiform gyrus. This inferior temporal brain region is preferentially 
involved in face processing (Kanwisher et al., 1997) and in interaction with the amygdala important 
for emotional face perception (Haxby, Hoffman, & Gobbini, 2002). The amygdala projects back to 
all levels o f the ventral visual stream (Amaral et al., 2003), influencing emotional face perception 
(Vuilleumier et al., 2004). This suggests that the increased fusiform gyrus responses are a potential 
consequence of increased amygdala responses, indicating that testosterone may influence the 
perception of emotional stimuli. The enhanced testosterone levels were positively correlated with 
superior frontal cortex responses, and negatively with orbitofrontal cortex responses. Whereas the 
superior frontal regions are implicated in the controlled regulation of affect, the inferior frontal 
regions are thought to regulate emotional responses automatically via direct connections to the 
amygdala (Ochsner & Gross, 2005; Phillips et al., 2003a; Stefanacci & Amaral, 2002; Stein et al., 
2007a). This suggests that the regulatory function of the orbitofrontal cortex decreases with 
increasing testosterone levels, potentially contributing to the observed amygdala disinhibition. In 
addition, the increased superior frontal cortex activity may reflect compensatory effort to regulate 
emotional responses.
The age related changes in neural responses to faces between young adulthood and midlife 
reported in the present study are similar to the changes that have been reported previously in 
elderly. While amygdala and fusiform gyrus activity decreases, prefrontal activity increases in 
healthy older men and women (> 60 years) in comparison to young adults (< 30 years) (Gunning- 
Dixon et al., 2003; Iidaka et al., 2002; Mather et al., 2004; Tessitore et al., 2005). However, to our 
knowledge, amygdala reactivity during midlife has not been investigated previously. The results of 
the present study show that amygdala reactivity in naturally cycling women already decreases 
before menopause, when androgen levels have declined to half the early adulthood level. The 
correlation between decreasing endogenous testosterone levels and decreasing neural responses, 
together with the testosterone induced amygdala reactivity increase, suggest that endogenous 
decreases in androgen levels may contribute to age related decreases in amygdala reactivity.
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Whereas the endogenous testosterone levels correlated positively with amygdala reactivity 
across individuals, the enhanced testosterone levels did not, even though testosterone reliably 
increased amygdala reactivity within subjects. This suggests that individual differences in amygdala 
sensitivity to high testosterone levels may exist. Furthermore, although the testosterone levels in 
the middle-aged women increased beyond the endogenous level of healthy young women, 
amygdala reactivity was similar. A recent study showed that a single testosterone administration 
also increases amygdala responses in healthy young women (Hermans et al., 2008). This suggests 
that testosterone increases amygdala reactivity within individuals regardless of baseline responses, 
but the absolute range of testosterone potentiated amygdala responses may differ across 
individuals and age.
The rapid effect o f nasal testosterone could be mediated by the rapid absorption of 
testosterone into the systemic circulation, but the nasal mucosa also provides a potential for 
pharmaceutical compounds to be available to the central nervous system directly (Hussain, 1998). 
Animal studies suggest that the timing of the testosterone induced effect (within 45 min) indicates 
a nongenomic mechanism of action, potentially mediated by its rapid conversion to estradiol or its 
neuroactive steroid 3a-androstanediol. Studies in male mice have shown that changes in sexual 
behavior can be mediated by changes in estrogen levels, due to rapid changes in aromatase activity 
(Balthazart, Baillien, & Ball, 2006; Taziaux, Keller, Bakker, & Balthazart, 2007). In addition, 
testosterone also has anxiolytic properties, and its rapid anxiolytic action appears mediated by 
conversion to 3a-androstanediol, which potentiates inhibitory neurotransmission by modulation of 
the GABAa receptor (Aikey et al., 2002). This latter action may be similar to that o f progesterone, 
which increases amygdala reactivity in healthy young women (van Wingen et al., 2008). Animal 
studies have demonstrated that the acute effects of progesterone are mediated by its neuroactive 
metabolite allopregnanolone that also exerts its action by binding to the GABAA receptor (Bitran 
et al., 1991; Bitran et al., 1995), suggesting a common pathway by which neuroactive steroids could 
modulate amygdala function.
Testosterone did not influence self-reported sexual arousal, state anxiety, and mood in the 
present study, which is in line with previous studies (van Honk et al., 2001). However, testosterone 
may change subjective arousal after appropriate stimulation. For example, whereas testosterone 
increases physiological but not subjective arousal after a single exposure to erotic movies, repeated 
exposure to erotic movies also increases subjective sexual arousal (Tuiten et al., 2000; Tuiten et al., 
2002). In addition, prolonged exposure to testosterone, or the prolonged withdrawal from 
testosterone, does influence the subjective experience. Mood and sexual function worsen after 
oophorectomy, when gonadal steroid hormone concentrations are chronically decreased. 
Moreover, subsequent testosterone treatment improves mood and sexual function in those women 
(Sherwin & Gelfand, 1985; Sherwin et al., 1985; Shifren et al., 2000). This suggests that although 
testosterone did not modulate self-report measures in the present study, it may do so after 
appropriate stimulation or repeated administration.
The present study shows that testosterone modulates amygdala activity in women, and animal 
research suggests that it may have a similar effect in men (Dimeo & Wood, 2006), for whom
72
testosterone also modulates mood and sexual function (Schmidt et al., 2004). Also the female 
gpnadal hormones progesterone (van Wingen et al., 2008) and presumably estradiol (Goldstein et 
al., 2005) modulate amygdala activity in women. The influence of these hormones in this study is 
likely limited, because the women were investigated during their follicular phase when 
progesterone and estradiol concentrations are lowest and similar to those in men. In addition, 
testosterone levels are also relatively low during the follicular phase, and increase during midcycle 
(Judd & Yen, 1973; Sinha-Hikim et al., 1998). Nevertheless, the sex hormones may interactively 
modulate amygdala activity. Furthermore, the amygdala is a sexual dimorphic brain structure with a 
relatively larger volume in men than women (Goldstein et al., 2001). The sex differences in 
amygdala structure and circulating hormone levels could mediate the sex differences in amygdala 
responsivity (Cahill, 2006; Hamann, 2005), and may thereby contribute to sex differences in the 
prevalence of psychiatric disorders (Kessler et al., 1994).
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ABSTRACT
Mood-congruent cognitive biases constitute critical factors for the vulnerability to depression and 
its maintenance. One important aspect is impaired memory for positive information during 
depression and after recovery. To elucidate its state (during depression only) and trait (during 
depression and recovery) related neural bases, we investigated medication free depressed, 
recovered, and healthy individuals with functional MRI while they memorized and recognized 
happy and neutral face stimuli. The imaging results revealed group differences in mood- 
incongruent successful memory encoding and retrieval activity already in the absence of significant 
memory performance differences. State effects were observed in the amygdala and posterior 
cingulate cortex. Whereas the amygdala was generally involved in memory formation, its activity 
predicted subsequent forgetting of neutral faces in currently depressed patients. Furthermore, the 
amygdala and posterior cingulate cortex were involved in memory retrieval of happy faces in 
currently depressed patients only. Trait effects were observed in the fusiform gyrus and prefrontal 
cortex. The fusiform gyrus was involved in memory formation and retrieval of happy faces in both 
patient groups, whereas it was involved in memory formation and retrieval of neutral faces in 
healthy individuals. Similar trait effects were observed during memory retrieval in the orbitofrontal 
cortex and left inferior frontal gyrus. Thus, while memory processing of positive information in the 
amygdala and posterior cingulate cortex normalizes after recovery from depression, memory 
processing in the fusiform gyrus and prefrontal cortex remains biased. These distinct neural 
mechanisms may respectively constitute symptom maintenance and cognitive vulnerability factors 
for depression.
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INTRODUCTION
Cognitive theories of depression hold that emotional processing biases constitute crucial 
components for the vulnerability to depression, and contribute to the maintenance of depressive 
symptoms (Beck & Clark, 1988; Mathews & MacLeod, 2005; Teasdale, 1983). One of these 
components is a mood-congruent memory bias, that is, better memory for mood-congruent 
information and worse memory for mood-incongruent information (Bower, 1981). Many studies 
have demonstrated mood-congruent memory effects in depressed patients and nonclinical samples 
(Blaney, 1986), but have mainly focused on negative information. However, a meta-analysis 
suggests that patients with a depressive disorder are particularly impaired in recalling positive 
information (Burt, Zembar, & Niederehe, 1995). After recovery from a major depressive episode 
(MDE), better memory for negative items is only apparent after sad mood induction, but worse 
memory for positive stimuli remains (Bradley & Mathews, 1988; Gilboa & Gotlib, 1997; Teasdale 
& Dent, 1987). This suggests not only mood state-dependent (state) but also mood state- 
independent (trait) contributions to memory function for positive information in depression. 
Identifying neural state and trait mechanisms that mediate these memory biases may reveal distinct 
neural mechanisms that constitute cognitive vulnerability and symptom maintenance factors for 
depression.
Neuroimaging studies in patients with major depression have revealed abnormal levels of 
activity during rest in various brain regions that are involved in emotional memory formation and 
retrieval in healthy individuals (LaBar & Cabeza, 2006), in particular the amygdala and prefrontal 
cortex (Drevets, 2000; Phillips et al., 2003b). These brain regions may thus mediate memory biases 
in depression. In healthy individuals, the amygdala is critically involved in the enhancement of 
memory for emotional events by facilitating memory processes in other brain regions (LaBar & 
Cabeza, 2006; McGaugh, 2004), whereas the prefrontal cortex mediates the effortful strategic 
memorization and retrieval of information (Miyashita, 2004). Indeed, initial studies that 
investigated memory encoding in depression suggest abnormal processing in the amygdala, 
hippocampus, and prefrontal cortex (Bremner, Vythilingam, Vermetten, & Charney, 2007; 
Bremner, Vythilingam, Vermetten, Vaccarino, & Charney, 2004; Hamilton & Gotlib, 2008; Ramel 
et al., 2007; Roberson-Nay et al., 2006). However, the neural mechanisms involved in memory 
processing biases for positive information are currently unknown.
In the current study, we investigated medication-naive patients with a first MDE and matched 
healthy individuals while they studied and recalled positive and neutral information. In a novel 
neuroimaging approach to disentangle state and trait effects, we also included a group of 
medication-free patients who had recovered from a first MDE. The participants were requested to 
memorize and recognize happy and neutral faces while their brain activity was measured with 
functional MRI. Faces are biologically salient stimuli that convey signals important for successful 
interpersonal communication and psychosocial interactions, and recognition memory for happy 
faces is impaired in depression (Gilboa-Schechtman, Erhard-Weiss, & Jeczemien, 2002; Ridout,
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Astell, Reid, Glen, & O'Carroll, 2003). The amygdala and prefrontal cortex are involved in the 
successful encoding and recognition o f faces, and their memory traces are presumably stored in a 
well defined region in the inferior temporal cortex that is preferentially involved in face perception 
(i.e., the fusiform gyrus) (Kanwisher et al., 1997; Miyashita, 1993; van Wingen et al., 2007). Thus, 
memory processing for happy faces could be altered in those brain regions. Furthermore, as 
abnormal amygdala responses during depression normalize after antidepressant treatment (Fu et 
al., 2004; Sheline et al., 2001), we hypothesized that memory processing biases in the amygdala 
could be mood state-dependent.
MATERIALS AND METHODS 
Participants
Twenty patients diagnosed with a first major depressive episode (MDE), 21 patients who had 
recovered from a first MDE, and 30 healthy individuals were included in this study. The currently 
depressed patients were investigated just prior to the start o f pharmacological or psychological 
treatment. The recovered patients had discontinued SSRI or venlafaxine (four patients) treatment 
for at least two months (mean ± SD = 11.1 ± 6.9), had received antidepressant treatment for 19.2 
(± 11.5) months, and were asymptomatic for 12.2 (± 6.9; all > 6) months (Frank et al., 1991). Major 
depressive disorder (MDD) was diagnosed using the Structured Clinical Interview for the DSM-IV 
(First, Spitzer, Gibbon, & Williams, 1996) by an experienced psychiatrist (P.v.E.). The additional 
inclusion criterion for the depressed group was a moderate to severe depression (> 17 on the 17- 
item Hamilton Rating Scale for Depression; HRSD), and for the recovered group the absence of 
clinically relevant symptoms defined as an HRSD score < 7 (Frank et al., 1991). Patients with other 
lifetime DSM-IV Axis-I disorders as assessed with the Mini International Neuropsychiatric 
Interview (MINI) (Sheehan et al., 1998) were excluded. Inclusion criteria for healthy individuals 
were no history of psychiatric disorders as confirmed by use of the MINI, and no history of 
psychiatric disorders in first degree relatives. All participants were physically healthy and currently 
medication free. Exclusion criteria were substance abuse or MRI contraindications.
Three participants were excluded from the analysis because o f brain abnormalities, four 
because of technical difficulties, and one because of not following task instructions. Therefore, the 
results are based on data of 18 depressed, 17 recovered, and 28 healthy individuals. These groups 
did not differ significantly in age, sex ratio, general intelligence, and handedness (see Table 6.1). 
The study was approved by the local ethics committee (CMO Regio Arnhem-Nijmegen, The 
Netherlands), and participants were recruited by local newspaper advertisements and our 
outpatient clinic. All participants gave written informed consent prior to participation.
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Procedure
All individuals participated on two study days in the afternoon. The first day started with a clinical 
interview to confirm the assignment to the depressed, recovered, or healthy control group (see 
above). Thereafter, participants completed the Beck Depression Inventory (BDI) (Beck, Ward, 
Mendelson, Mock, & Erbaugh, 1961), the trait version of the State Trait Anxiety Inventory (STAI) 
(Spielberger et al., 1970), and the Edinburgh Handedness Inventory (EHI) (Oldfield, 1971). The 
scanning session took place on the second day, after which the participants completed the state 
version o f the STAI. Finally, neuropsychological function was assessed using a neuropsychological 
test battery (see Table 6.1).
Memory paradigm
This paradigm has been used previously with healthy volunteers (van Wingen et al., 2007). The 
participants completed three study-test cycles during scanning. During study, they were requested 
to memorize intermixed pictures of faces with a happy or neutral facial expression, while making a 
gender decision. During test, they were requested to recognize these pictures among intermixed 
new pictures, and to make an old, new, or unsure decision. For 3 depressed, 2 recovered, and 6 
healthy individuals, only two study-test cycles were available.
The stimuli consisted of faces with a happy or neutral emotional expression and with direct 
gaze direction. They were derived from different stimulus sets (Ekman & Friesen, 1976; Lundqvist 
et al., 1998; Martinez & Benavente, 1998) and the internet. All photos were edited to produce oval 
grayscale pictures that showed the face from chin to forehead and excluded the ears. The 
emotional content of the stimuli was validated in a pilot experiment with other healthy participants 
(N = 8, age range = 21-30 years). The valence rating distributions o f the selected 360 happy (mean 
± SD = 7.0 ± 0.3) and 360 neutral faces (5.1 ± 0.5) did not overlap, and the amount o f features did 
not differ between the valence conditions (24% glasses, 6% facial hair, and 4% non-Caucasian; 
X2(3) = 0.5, NS). The stimuli were subsequently divided over six study-test cycles of 120 faces each, 
that did not differ in the amount of features (x2(15) = 0.8, NS), nor in emotional valence (F < 1). 
Each participant only received three of the six cycles, which was counterbalanced across subjects. 
Sixty stimuli per cycle were used as study items, and 60 as distractors during test, which was also 
counterbalanced across subjects. The stimuli and 10 null events (2s) per cycle phase (60 in total) 
were pseudo-randomly intermixed, such that there were no more than four consecutive 
presentations per emotion or gender, or old/new status of the stimulus. All faces were presented 
for 0.8 s with an inter stimulus interval of 3.3-4.3 s.
Recognition memory performance was assessed using signal detection theory. The 
discrimination index d’ was calculated as measure for the classification accuracy o f old/new 
decisions, and the bias index C as measure for the response bias towards identifying stimuli as old 
or new (Snodgrass & Corwin, 1988). These measures were based on hit and false alarm rates after 
exclusion of unsure responses.
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MRI data acquisition
MR data were acquired with a 1.5 T Siemens (Erlangen, Germany) Sonata MR scanner, equipped 
with a standard head coil. T2*-weighted BOLD images were acquired using EPI, with each image 
volume consisting o f 33 axial slices (3 mm, 0.5 mm slice-gap, TR = 2.290 s, TE = 30 ms, 64 x 64 
matrix, FOV = 224 mm, FA = 90°). In addition, a high resolution Tl-weighted structural MR 
image was acquired for spatial normalization procedures (3D MP-RAGE, 1 x 1 x 1 mm3 voxels).
fMRI data analysis
Image analysis was performed with SPM5 (http://www.fil.ion.ucl.ac.uk/spm). The first five EPI- 
volumes were discarded and the remaining images were realigned to the first volume. Images were 
then coregistered to the anatomical scan, corrected for differences in slice acquisition time, 
spatially normalized to the MNI T1 template, resampled into 2 x 2 x 2 mm3 voxels, and spatially 
smoothed (8 mm FWHM).
Subsequent hits and subsequent misses were modeled separately for the study phase, as were 
hits, misses, correct rejections, and false alarms for the test phase. These conditions were modeled 
separately for happy and neutral faces. Stimuli with an incorrect gender decision or omission 
during study, or with an unsure response or omission during test, were included in a condition of 
no interest. The explanatory variables (0.8 s) and null events (2 s) were temporally convolved with 
the canonical hemodynamic response function o f SPM5. In addition, the realignment parameters 
were included to model potential movement artifacts, as well as a high-pass filter (cut-off 1/128 
Hz). The data were proportionally scaled to account for various global effects, and temporal 
autocorrelation was modeled with an AR(1) process. The relevant parameter images contrasting 
each condition to the explicitly modeled null events were entered in a mixed-model ANOVA with 
non-sphericity correction for dependent measures.
Separate conjunction analyses were performed for memory encoding and recognition, to 
identify brain regions involved in successful memory encoding or recognition and in which the 
influence of emotion on memory processes differed between groups. These analyses tested the 
global null hypothesis using the minimum T statistic as implemented within SPM5 (Friston et al.,
2005) between main effects of memory and group x memory x emotion interactions. State effects 
were assessed by testing the conjunction o f the main effect of memory (encoding: subsequent hits 
vs. subsequent misses; recognition: hits vs. misses), the group x memory x emotion (2 x 2 x 2) 
interaction between the depressed and control group, and the 2 x 2 x 2 interaction between the 
depressed and recovered group. This analysis tests the significant overlap of differences between 
depressed and healthy individuals and differences between depressed and recovered individuals in 
emotion specific successful encoding or recognition in brain regions that are generally involved in 
successful encoding or recognition. Analogously, trait effects were assessed by testing the 
conjunction of the main effect of memory, the 2 x 2 x 2 interaction between the depressed and 
control group, and the 2 x 2 x 2 interaction between the recovered and control group. This
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analysis tests the significant overlap of differences between depressed and healthy individuals and 
differences between recovered and healthy individuals in emotion specific successful memory 
encoding or recognition in brain regions that are generally involved in successful encoding or 
recognition. In addition, these analyses were also performed with sex as covariate, to exclude the 
possibility that remaining sex differences might contribute to the observed group effects, even 
though the sex ratio did not differ significantly between groups. Correcting for sex did not change 
the pattern o f results, and the results are reported for the analyses without covariate.
Statistical tests were family-wise error rate corrected for multiple comparisons across the 
entire brain, or for the search volume for regions of interest using a small volume correction (SVC) 
(Worsley et al., 1996). Search volumes for the amygdala, hippocampus, left inferior prefrontal 
cortex, and orbitofrontal cortex were anatomically defined (Maldjian et al., 2003; Tzourio-Mazoyer 
et al., 2002). Face responsive regions in the fusiform gyrus were defined as spheres with 10 mm 
radii around previously reported coordinates (Kanwisher et al., 1997), which were converted into 
MNI space (http://imaging.mrc-cbu.cam.ac.uk/imaging/MniTalairach). The mean activity within 
significant conjunction clusters (p < 0.001, uncorrected) was extracted for subsequent one-sample 
t-tests (one-tailed), to assess whether each condition separately showed significant memory effects. 
Finally, to investigate whether the encoding and recognition conjunction clusters were within the 
same brain region, the anatomical overlap was assessed using Fisher’s combined probability test 
(both p < 0.01 for a conjoint probability of p < 0.001, uncorrected).
RESULTS 
Clinical and neuropsychological test data
The HRSD scores confirmed that the currently depressed patients had a moderate to severe 
depression, and that the currently asymptomatic patients had recovered from depression. As 
expected, the depressed patients scored higher on negative mood (BDI) and state and trait anxiety 
(STAI) on the self-report questionnaires than the recovered patients, and the recovered patients 
scored higher than the healthy individuals (all p < 0.05; see Table 6.1). However, no significant 
differences between the groups were observed on any of the neuropsychological tests, including 
measures of IQ, visual and declarative memory, attention, psychomotor speed, and executive 
function (all p > 0.1; see Table 6.1). These results show that this medication free population of 
first-episode depressed patients had no apparent impairment in neuropsychological functioning.
Behavioral performance
The gender decision during face memory encoding was made more accurately for male than female 
faces (mean ± SEM; male: 95.5 ± 0.5 %, female: 92.1 ± 0.6 %; F(1,60) = 19.5, p < 0.001), and
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faster for male than female faces (male: 1092 ± 39 ms, female: 1126 ± 38 ms; F(1,60) = 15.5, p < 
0.001). However, no significant differences between groups were observed (main effects and 
interactions; all p > 0.5).
Recognition memory accuracy for happy and neutral faces did not differ significantly (d’; 
happy: 0.89 ± 0.05, neutral: 0.94 ± 0.05; p > 0.3). Most importantly, no significant differences in 
memory performance between groups were observed (main effect and interaction; both p > 0.6). 
Although response bias was more liberal for happy than neutral faces (C; happy: -0.10 ± 0.04, 
neutral: -0.03 ± 0.04; F(1,60) = 10.3, p = 0.002), no significant differences between groups were 
observed (main effect and interaction; both p > 0.8). Response times for memory decisions were 
fastest for hits and slowest for misses (hits (1312 ± 34 ms) < false alarms (1416 ± 40 ms) < correct 
rejections (1489 ± 41 ms) < misses (1580 ± 47 ms); F(3,58) = 42.5, p < 0.001), but no significant 
effects o f emotion or group were observed (main effects and interactions; all p > 0.3). In summary, 
no significant memory performance differences were observed, indicating that the depressed and 
recovered patients were unimpaired in the intentional learning and recognition of happy and 
neutral faces.
Imaging results
Memory encoding
Brain regions generally involved in memory formation o f faces were identified first. This main 
effect of encoding success (i.e., subsequent hits > subsequent misses) showed that regions in the 
inferior temporal cortices (including the fusiform gyrus), anterior medial temporal lobe (including 
the amygdala and hippocampus), left inferior frontal gyrus, and right intraparietal sulcus were 
generally involved in memory formation of faces (p < 0.001, uncorrected, cluster > 20 voxels).
State and trait effects on emotion specific memory formation and retrieval were identified 
with conjunction analyses (see Materials and Methods). These analyses showed that state effects on 
emotion specific memory formation were mediated by the amygdala (left: (-26, -4, -14), Z = 3.9, 
pSVC = 0.009; right: (26, -8, -12), Z = 3.4, pSVC = 0.040). Subsequent simple effect tests showed 
that whereas the left amygdala was involved in memory formation of happy and neutral faces in 
healthy individuals, it was only involved in memory formation of happy faces in current 
depression. Moreover, increased amygdala responses to neutral faces predicted subsequent 
forgetting in current depression. Comparing responses for subsequently remembered and 
subsequent forgotten neutral faces separately, this appeared due to larger amygdala responses in 
current depression than healthy individuals to neutral faces that were later forgotten (subsequent 
misses: t(44) = 3.2, p = 0.003; subsequent hits: p > 0.9). Furthermore, although the activity pattern 
in recovered patients was similar to that o f healthy individuals, the amygdala did not reliably 
predict memory formation of happy and neutral faces in recovered patients (see Fig. 6.1), likely due 
to smaller effect size and fewer participants. The activity pattern was similar in the right amygdala,
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although the subsequent memory effect for happy faces in healthy individuals did not reach 
statistical significance.
Table 6.1. Demographic, clinical, and neuropsychological test data of currently depressed (N  — 18), recovered (N  -  
17), and healthy individuals (N  — 28).
Depressed Recovered Healthy pa
Age, years 33.3 (11.7) 33.9 (11.5) 35.8 (12.0) 0.76
Sex, male:female 7:11 4:13 13:15 0.31b
Handedness, left:right 0:18 1:16 1:27 0.61b
HRSD 21.8 (4.2) 3.2 (2.0) - < 0.001c
BDI 27.4 (8.9) 9.2 (4.5) 2.2 (3.1) < 0.001d
STAI Trait 53.7 (12.6) 43.9 (7.9) 30.7 (6.2) < 0.001d
State 43.8 (8.7) 37.1 (5.6) 32.6 (7.2) < 0.001d
DART-IQ' 92.8 (14.0) 99.7 (8.7) 101.4 (16.1) 0.12
Episodic memory
CFT 23.4 (5.3) 21.6 (6.2) 23.8 (5.3) 0.41
AVLT Immediate recall, no 51.3 (10.7) 54.5 (8.2) 50.2 (7.8) 0.27
Delayed recall, no 10.8 (3.3) 11.4 (2.3) 11.1 (2.2) 0.84
Correctly recognized, no 29.3 (1.1) 29.7 (0.6) 29.5 (0.9) 0.48
Attention and psychomotor speed
SDMT, no. completed 62.3 (10.0) 64.2 (8.9) 61.0 (10.8) 0.60
TMT Part A, s 29.4 (10.6) 26.3 (7.2) 27.7 (6.4) 0.52
Executive function
TMT Interference, % 57.0 (42.6) 57.3 (60.2) 50.9 (41.4) 0.87
WCST Categories completed, no 5.1 (1.9) 4.9 (1.9) 5.7 (1.1) 0.29
Trials administered, no 90.4 (22.1) 99.3 (22.2) 88.7 (19.0) 0.26
Perseverative responses, no 13.5 (14.8) 19.5 (16.3) 10.3 (10.6) 0.12
Abbreviations: HRSD, Ham ilton Rating Scale fo r Depression; BDI, Beck D epression Inventory; STAI, 
State Trait Anxiety Inventory; DART, D utch  version o f  the National Adult Reading Test (Schmand, 
Lindeboom, & van Harskamp, 1992); CFT, Rey-Osterrieth Complex Figure Test (Osterrieth, 1944); AVLT, 
D utch modified version o f  the Rey Auditory Verbal Learning Test (Saan & Deelman, 1986); SDMT, Symbol 
Digit Modalities Test (Smith, 1982); TM T, Trail Making Test (Lezak, 1995); WCST, W isconsin Card Sorting 
Test (Heaton, Chelune, Talley, Kay, & Curtiss, 1993).
D ata are expressed as m ean (SD).
a One-way A N O V A
b Pearson %2
c Independent-sam ple t-test
d Depressed > Recovered > Healthy; independent-sam ple t-tests
e The D A R T IQ  estimate is ~ 0.5 SD lower than  the W echsler Adult Intelligence Scale estimate (Bouma, 
Mulder, & Lindeboom , 1998).
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Figure 6.1. State effects during memory encoding of happy (H) and neutral (N) faces in the amygdala. The figures 
show a coronal slice (y = -4; left = left) at the maximum of the significant conjunction cluster (p < 0.001, cluster > 
20 voxels), and the corresponding parameter estimates for depressed, recovered, and healthy individuals (i.e., 
subsequent hits - subsequent misses; arbitrary units, mean ±SEM ).
Figure 6.2. Trait effects during memory encoding of happy (H) and neutral (N) faces in the fusiform gyrus. The 
figures show a coronal slice (y = -52; left = left) at the maximum of the significant conjunction cluster (p < 0.001, 
cluster >20 voxels), and the corresponding parameter estimates for depressed, recovered, and healthy individuals (i.e., 
subsequent hits - subsequent misses; arbitrary units, mean ±SEM ).
Trait effects on emotion specific memory formation were mediated by the right fusiform gyrus 
((40, -52, -8), Z = 4.3, psvc = 0.002). Subsequent simple effect tests showed that whereas the 
fusiform gyrus was involved in memory formation of neutral but not happy faces in healthy 
individuals, this pattern was reversed in both depressed and recovered patients, in whom the 
fusiform gyrus was involved in memory formation of happy but not neutral faces (see Fig. 6.2).
Recognition memory
Brain regions generally involved in memory retrieval of faces were identified first. This main effect 
of recognition success (i.e., hits > misses) showed that regions in the posterior cingulate cortex, left 
middle frontal gyrus, superior medial frontal gyrus, orbitofrontal cortex, left middle temporal
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gyrus, caudate nuclei, and left angular gyrus were generally involved in memory retrieval of faces (p 
< 0.001, uncorrected, cluster > 20 voxels).
State effects on emotion specific memory retrieval were mediated by the left amygdala ((-24, 0, 
-28), Z = 3.5, pSVC = 0.033), in the same brain area as during memory encoding (p < 0.001, 
uncorrected). Subsequent simple effect tests showed that the amygdala was involved in memory 
retrieval of happy faces in depressed patients, whereas it was not in recovered patients and healthy 
individuals. A similar pattern of results was observed in the posterior cingulate cortex ((-10, -34, 
40), Z = 4.9, p = 0.057, corrected), which was involved in memory retrieval of happy faces in 
current depression and of neutral faces in healthy individuals (see Fig. 6.3).
Trait effects on emotion specific memory retrieval were mediated by the orbitofrontal cortex 
((22, 34, -14), Z = 3.9, pSVC = 0.038)), left inferior frontal gyrus ((-44, 36, 10), Z = 4.4, pSVC = 
0.007), and right fusiform gyrus ((44, -48, -12), Z = 4.5, pSVC = 0.001). Subsequent simple effect 
tests showed that the orbitofrontal cortex and left inferior frontal gyrus were involved in memory 
retrieval of happy faces in depressed and recovered patients, whereas those brain regions were 
involved in memory retrieval of neutral faces in healthy individuals. Also the right fusiform gyrus 
demonstrated this pattern of results (see Fig. 6.4), which was similar to the pattern during memory 
encoding and in the same brain region (p < 0.001, uncorrected).
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Figure 6.3. State effects during memory retrieval of happy (H) and neutral (N) faces in the amygdala and posterior 
cingulate cortex. The figures show slices at the maximum of the significant conjunction clusters (p < 0.001, cluster > 
20 voxels), and the corresponding parameter estimates for depressed, recovered, and healthy individuals (i.e., hits - 
misses; arbitrary units, mean ±SEM ). (A) Left amygdala (y = 0), and (B) posterior cingulate cortex (x = -10).
84
Figure 6.4. Trait effects during memory retrieval of happy (H) and neutral (N) faces in the orbitofrontal cortex, 
inferior frontal gyrus, and fusiform gyrus. The figures show coronal slices (left = left) at the maximum of the 
significant conjunction clusters (p < 0.001, cluster > 20 voxels), and the corresponding parameter estimates for 
depressed, recovered, and healthy individuals (i.e., hits - misses; arbitrary units, mean ±  SEM). (A) Orbitofrontal 
cortex (y = 34), (B) inferior frontal gyrus (y = 36), and (C) fusiform gyrus (y = -48).
DISCUSSION
The key finding of this study is that distinct neural structures mediate state and trait dependent 
memory processing biases for positive information in first-episode major depression. Processing 
biases in the amygdala and posterior cingulate cortex were only apparent in currently depressed 
patients, whereas processing biases in the fusiform gyrus and prefrontal cortex were also present in
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recovered patients. These results suggest that the role of the amygdala and posterior cingulate 
cortex to memory processing is affected by mood symptoms, which may contribute to symptom 
maintenance during depression. Conversely, the role of the fusiform gyrus and prefrontal cortex 
biases memory processing independently of mood state, and may contribute to cognitive 
vulnerability to depression. Furthermore, the remaining processing biases after recovery may 
explain the high rate of relapse (Mueller et al., 1999).
Behavioral studies suggest that depressed patients are particularly impaired in recalling positive 
information (Burt et al., 1995), and have shown impaired recognition memory for happy faces after 
incidental learning (Gilboa-Schechtman et al., 2002; Ridout et al., 2003). However, the currently 
depressed and recovered patients demonstrated adequate recognition memory performance after 
intentional learning of happy and neutral faces. This could be explained in part by differences 
between incidental and intentional learning, or the good neuropsychological functioning of the 
participants. Neither the medication-naive first-episode depressed patients nor the medication free 
patients who had recovered from a first depressive episode showed neuropsychological 
impairments. The absence of performance differences is advantageous for interpretation of the 
imaging results, because differences in performance may change the observed neural effects 
(Morcom, Li, & Rugg, 2007). In that respect, the present study reveals a processing bias for mood- 
incongruent information already in the absence of behavioral deficits in brain regions important 
for memory, which may mediate mood-congruent memory biases in depression.
The results showed state effects in the amygdala during both memory formation and retrieval, 
but in opposite directions for different emotions. Whereas enhanced amygdala reactivity during 
encoding predicted subsequent forgetting of neutral faces in currently depressed patients, its 
activation during recognition was associated with the successful recognition of happy faces. In 
general, increased amygdala activity is thought to enhance memory by facilitating memory 
processes in other brain regions (Kilpatrick & Cahill, 2003; LaBar & Cabeza, 2006; McGaugh, 
2004). However, the present results suggest that enhanced amygdala reactivity to ambiguous 
stimuli (i.e., neutral faces) in currently depressed patients may prevent efficient memory processing, 
possibly due to an information overload or increased rumination, thereby counteracting its usual 
role in memory formation. Conversely, its involvement in the successful recognition of happy 
faces and overlap with encoding activity suggests that symptomatic patients may need a larger 
reinstatement of encoding-related neural activity to reactivate memory representations of happy 
faces (Johnson & Rugg, 2007; Morris, Bransford, & Franks, 1977; Tulving & Thomson, 1973). A 
similar effect was observed in the posterior cingulate cortex, which may shift attention to internally 
generated memory representations (Wagner et al., 2005). This suggests that depressed patients may 
need to evaluate the emotional aspect of positive events to a larger extent to retrieve them 
successfully from memory.
Trait effects were observed in the fusiform gyrus during both memory formation and 
retrieval. This brain region is preferentially involved in face processing (Kanwisher et al., 1997), 
and face memory traces are presumably stored here (Fenker, Schott, Richardson-Klavehn, Heinze, 
& Duzel, 2005; Miyashita, 2004). Fusiform gyrus responses to happy faces are relatively reduced
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during depression (Surguladze et al., 2005), which may contribute to the impaired identification of 
happy faces in depressed patients (Surguladze et al., 2004). The larger involvement of this brain 
region to the successful encoding of happy faces in depressed patients suggests that more neural 
resources are necessary to encode stimuli that are incongruent with ones cognitive schema, 
regardless of current mood. Again, the overlap between study and test activity suggests that 
depressed patients may need a larger reinstatement of encoding-related neural activity to reactivate 
memory representations of happy faces (Johnson & Rugg, 2007). Additional trait effects were 
observed in the orbitofrontal cortex and left inferior frontal gyrus during memory retrieval. The 
involvement of these brain regions during the successful recognition of happy faces was relatively 
increased in depressed and recovered patients. The prefrontal cortex exerts executive control 
during the retrieval o f memory representations in the inferior temporal cortex (Miyashita, 2004; 
Tomita et al., 1999), o f which the fusiform gyrus is part. The larger contribution of the prefrontal 
cortex and fusiform gyrus to memory retrieval may suggest that more strategic retrieval attempts 
are necessary to successfully retrieve happy faces from memory, indicating that depressed and 
recovered patients require more top-down control to retrieve positive information.
Limitations of this study include the use o f a cross-sectional design and potential indirect 
medication effects. Although the groups did not differ significantly in demographic characteristics 
and neuropsychological test performance, and all participants were currently free o f medication, 
the recovered patients had received pharmacotherapy prior to investigation. Longitudinal studies 
are required to conclusively identify state and trait effects and exclude potential indirect medication 
effects, and studies with individuals at risk for depression are necessary to establish that trait 
effects are already present premorbidly, as has been observed for certain personality characteristics 
and psychosocial disability (Ormel, Oldehinkel, Nolen, & Vollebergh, 2004; Ormel, Oldehinkel, & 
Vollebergh, 2004).
In conclusion, the unique contribution of this study is demonstrating that the amygdala and 
posterior cingulate cortex mediated memory processing biases in a state-dependent manner and 
the fusiform gyrus and prefrontal cortex in a trait-dependent manner. These results suggest that 
different neural mechanisms constitute cognitive vulnerability and symptom maintenance factors 
for depression (Beck & Clark, 1988; Mathews & MacLeod, 2005; Teasdale, 1983). Whereas altered 
amygdala and posterior cingulate cortex memory function may contribute to symptom 
maintenance, abnormal prefrontal cortex and fusiform gyrus function may contribute to cognitive 
vulnerability.
87

7 SUMMARY AND GENERAL DISCUSSION
The central aim o f this thesis was to elucidate biological mechanisms that contribute to variability 
in amygdala function, and whether abnormal amygdala processing during depression is a stable 
characteristic or is dependent on the depressive mood. Although the amygdala is consistently 
involved in emotion processing (Phelps, 2006; Sergerie et al., 2008), the magnitude o f its 
involvement is highly variable among individuals. Amygdala processing is not only altered in 
patients suffering from certain psychiatric disorders, but also among healthy individuals. The 
differences among individuals are relatively stable over time, which explains up to 30% of the 
variance in test-retest measurements (Johnstone et al., 2005; Manuck et al., 2007). This suggests 
that a large part of the individual differences in amygdala reactivity are explained by the 
combination of stable characteristics of an individual (trait factors), but also that it is dependent on 
other factors that reflect the individual’s state (state factors). However, the question remains what 
these state and trait factors are. The results that are described in Chapters 2 to 5 demonstrate that 
both genes and hormones form part of the biological factors that explain variability in amygdala 
function among healthy individuals. Furthermore, Chapter 6 demonstrates that the depressive 
mood during a major depressive episode explains abnormal memory processing in the amygdala in 
major depression. The results o f these studies are described and discussed in more detail below.
Brain-derived neurotrophic factor gene
The results presented in Chapter 2 show that a single nucleotide polymorphism in the BDNF  gene 
(Val66Met) affects memory processing in the amygdala. The volunteers were requested to 
memorize and subsequently recognize pictures of faces. During memory encoding, BDNF  Met 
allele carriers showed a larger differential response between later remembered and later forgotten 
faces than ValVal homozygotes. This larger contribution of the amygdala to memory formation in 
Met carriers was qualified by a significant interaction with sex, which revealed that the effect of 
BDNF  genotype was specific to males.
The valine (Val) to methionine (Met) substitution in the prodomain o f the encoded protein 
decreases the activity-dependent secretion o f BDNF, and impairs memory performance in specific 
memory tasks (Egan et al., 2003). Previous neuroimaging studies have mainly investigated the 
potential role of the hippocampus in BDNF  Val66Met effects, probably because BDNF is crucially 
involved in synaptic plasticity in hippocampal neurons (Pang et al., 2004). Those studies have 
shown that Met allele carriers have smaller hippocampal volumes (Pezawas et al., 2004) and 
reduced hippocampal activity during memory encoding and retrieval (Hariri et al., 2003a). 
However, recent animal studies have demonstrated that BDNF also mediates amygdala-dependent 
processes such as fear learning (Ou & Gean, 2006; Rattiner et al., 2004), and that the Val66Met 
polymorphism also influences anxiety (Chen et al., 2006). Our results are the first demonstration 
that variance in the BD NF  gene also affects memory processing in the human amygdala.
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The BDNF  Val66Met polymorphism modulated the contribution o f the amygdala to memory 
formation of faces in males only, which is in line with the effects of BDNF  Val66Met on 
depression vulnerability. In parallel with the animal and human neuroimaging studies, human 
genetic studies have investigated the relative occurrence of different BDNF  genotypes in patients 
with major depression. A recent meta-analysis o f these genetic association studies revealed that 
male Met allele carriers are at increased risk of depression, but that the Val66Met polymorphism 
does not influence depression risk in females (Verhagen et al., 2008). Our neuroimaging results 
support this sex-specific effect of BD NF  Val66Met, and suggest a possible neural mechanism that 
may mediate it.
The absence of BDNF  gene effects in women may be due to other influences on gene 
expression in females. One possibility is that BDNF levels are more under hormonal control in 
females, irrespective of BDNF  genotype, as suggested by the influence of the menstrual cycle on 
BDNF plasma levels (Begliuomini et al., 2007). In addition, animal studies have demonstrated that 
the estrous cycle also modulates hippocampal BDNF gene expression (Gibbs, 1998), and that 
estradiol’s regulation of dendritic spine density in the hippocampus is mediated by BDNF (Murphy 
et al., 1998). This suggests that if BD NF  genotype has an influence on memory processing in the 
amygdala in women, it is most likely dependent on the hormonal milieu, which could be addressed 
in future studies.
Progesterone
The results presented in Chapters 3 and 4 demonstrate that progesterone modulates amygdala 
function in women. To investigate progesterone’s effect on amygdala function, we administered a 
single progesterone dose to healthy young women in a placebo-controlled, crossover manner, and 
performed two experiments. The first experiment was done after the progesterone level had 
increased from the follicular phase baseline to the range that is reached during the luteal phase of 
the menstrual cycle. This increase in progesterone concentration enhanced amygdala activity 
during the perception of faces with negative facial expressions.
The rapid effects o f progesterone are mediated by the action of its neuroactive metabolite 
allopregnanolone on the GABAa receptor, which facilitates GABAergic neurotransmission (Bitran 
et al., 1995). This suggests that the administration o f progesterone should decrease amygdala 
reactivity (Akwa et al., 1999), rather than increasing it. However, there are at least two explanations 
for our paradoxical result. One is that progesterone metabolites produce paradoxical effects after 
the prolonged withdrawal of allopregnanolone (Smith et al., 2006). The human follicular phase 
represents such a period, when progesterone and allopregnanolone levels are at baseline for about 
two weeks. Another explanation is that the direct effects of allopregnanolone are dependent on its 
concentration. The behavioral effects o f allopregnanolone appear biphasic, with disinhibition at 
moderate levels and sedation at higher concentrations, which is also observed with other GABAa 
receptor agonists (Backstrom et al., 2003). For example, moderate doses o f allopregnanolone 
increase aggression in mice whereas higher doses decrease aggression, and even higher doses
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decrease locomotor activity (Fish et al., 2001). Importantly with respect to depressive mood, 
women that obtain moderate allopregnanolone concentrations during hormonal replacement 
therapy report more negative mood symptoms than those that obtain lower and higher 
concentrations (Andréen et al., 2006).
The second experiment was performed when the progesterone and allopregnanolone levels 
had increased further to levels that are reached during pregnancy (Luisi et al., 2000). The task 
consisted of memorizing and subsequently recognizing pictures o f faces. Amygdala responses to 
the face stimuli were lower during these high hormone levels than during the placebo condition. 
Together with the previous experiment, these results indeed suggest a biphasic effect of 
allopregnanolone on amygdala responsivity, with increases at moderate levels and decreases at 
higher levels. However, this conclusion is based on two separate experiments with different tasks 
and stimuli. Future studies may more directly test this possibility, for example in a placebo­
controlled study with moderate and high doses of progesterone or allopregnanolone.
The high progesterone concentration in the second experiment also decreased memory 
performance, in line with previous progesterone administration studies (Freeman et al., 1993; 
Freeman et al., 1992) and the worsening of memory during pregnancy (Keenan et al., 1998; Sharp 
et al., 1993). Importantly, the neuroimaging results showed that progesterone decreased neural 
responses in those brain regions that also supported memory formation and retrieval, but did not 
modulate successful encoding and recognition processes as such. Moreover, the progesterone 
induced decrease in amygdala and fusiform gyrus responses during memory encoding, and 
prefrontal cortex and fusiform gyrus responses during retrieval, predicted the decrease in memory 
performance. These results suggest that allopregnanolone impairs memory by reducing the 
probability of recruiting those brain regions that support memory formation and retrieval, rather 
than modulating the processes that underlie memory formation and retrieval per se.
The effect of moderate progesterone increases on amygdala reactivity suggest that changes in 
amygdala activity during parts of the menstrual cycle when progesterone levels are high 
(Ossewaarde et al., 2008) are mediated by progesterone. Moreover, women with PMDD are more 
sensitive to progesterone level changes (Schmidt et al., 1998), and show increased amygdala 
responsivity during the symptomatic phase of the menstrual cycle (Protopopescu et al., 2008). The 
results o f our first experiment suggest that the potentiation of amygdala reactivity is mediated by 
progesterone. This may be augmented in women with PMDD and induce their negative mood 
symptoms, which could be investigated in future studies.
The results of our second experiment show that progesterone not only modulates emotion 
processing, but that it also affects neural processes involved in cognition. Although the effect of 
progesterone on memory processing was observed at relatively high concentrations, progesterone 
may also be critical in modulating (other) cognitive processes during high progesterone phases of 
the menstrual cycle (e.g., Fernández et al., 2003).
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Testosterone
The results presented in Chapter 5 demonstrate that the age-related decline in testosterone levels is 
associated with decreasing amygdala responsivity in women during the perception of negative face 
stimuli. To provide more direct evidence that this was mediated by testosterone, we directly 
administered testosterone in a placebo-controlled, crossover manner to healthy middle-aged 
women. Testosterone increased their amygdala responsivity to the level o f young women.
Healthy elderly show a decrease in amygdala responsivity (Iidaka et al., 2002), which they 
appear to compensate with a larger recruitment o f the prefrontal cortex (Gunning-Dixon et al., 
2003; Tessitore et al., 2005). Many biological factors may mediate these age differences that may 
become more apparent with increasing age. One important hormonal factor in women may be 
menopause, with its marked changes on progesterone and estradiol levels, but our results suggest 
that these changes already occur before menopause. The concentrations of androgens have already 
declined to half of their early adulthood levels by middle-age (Davison et al., 2005; Zumoff et al., 
1995), indicating that this could be one of the most important hormonal determinants o f age- 
related changes in amygdala function.
Our results and that o f another recent study (Hermans et al., 2008) demonstrate that 
experimentally enhancing testosterone levels increases amygdala responsivity. However, our 
evidence for lower amygdala reactivity with lower testosterone levels was correlational. Animal 
studies suggest that testosterone may affect amygdala function in both directions, because it also 
controls amygdala volume in both directions (Cooke, Tabibnia, & Breedlove, 1999). To investigate 
this directly, future studies may experimentally decrease testosterone levels. One possibility is to 
administer a gonadotropin releasing hormone agonist for several weeks to men, which eventually 
produces a temporary hypogonadal state (cf., Schmidt et al., 2004).
Major depression
To investigate whether altered memory processing in the amygdala in depressive patients is 
dependent of their mood state, or reflects more the underlying disease vulnerability, three groups 
of volunteers participated in the study described in Chapter 6. One group of patients was 
experiencing a first major depressive episode and participated just prior to treatment, one group of 
patients had just recovered from a first episode and successfully finished pharmacotherapy, and 
one group o f volunteers had never experienced a depression. The volunteers were requested to 
memorize and subsequently recognize pictures of happy and neutral faces while their brain activity 
was measured with functional MRI. The results showed that whereas the amygdala was generally 
involved in the successful encoding o f faces, its activity only predicted subsequent forgetting of 
neutral faces in the currently depressed patients. Furthermore, the amygdala was involved in 
memory retrieval o f happy faces in currently depressed patients only. These results therefore 
suggest that altered memory processing in the amygdala in patients with major depression is 
dependent on mood state, just as in healthy individuals (Fitzgerald et al., 2008).
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Previous neuroimaging studies demonstrated that amygdala hyperresponsivity normalizes 
during successful antidepressant treatment (Fu et al., 2004; Sheline et al., 2001), but this could also 
be related to medication use. However, preliminary results o f a recent study indicate that increased 
amygdala reactivity also normalizes after cognitive therapy (DeRubeis, Siegle, & Hollon, 2008), and 
is therefore not mediated by the direct effects o f antidepressants. Importantly, our results 
demonstrate that memory processing in the amygdala also normalizes after recovery from 
depression in patients who did not use any medication or who had discontinued their 
antidepressant treatment. Nevertheless, indirect long-term effects of the medication remain 
possible.
In contrast to amygdala responsivity, other studies have demonstrated that resting amygdala 
metabolism and blood flow remains elevated in unmedicated patients with unipolar or bipolar 
depression after recovery (Drevets et al., 2002; Drevets et al., 1992). Thus, whereas transient 
amygdala responses to environmental stimuli normalize after recovery, sustained amygdala activity 
remains elevated. This suggests that increased phasic amygdala activity may represent a state factor 
of depression, and increased tonic amygdala activity a trait factor, which could be investigated in 
combined activation and resting state perfusion studies.
State-related cognitive processes are thought to contribute to depressive symptom 
maintenance, and trait-related processes to depression vulnerability (Beck & Clark, 1988; Mathews 
& MacLeod, 2005; Teasdale, 1983). Whereas memory processing normalized after recovery from 
depression in the amygdala, it remained altered in the prefrontal cortex. Our results therefore 
suggest that the amygdala mainly contributes to symptoms, and the prefrontal cortex to depression 
vulnerability. However, future prospective studies in individuals at risk for depression are necessary 
to establish the dissociation between symptom maintenance and vulnerability, and to rule out 
possible indirect medication effects.
Perspective
The results presented in this thesis show that genes and hormones have a profound influence on 
amygdala processing, and thereby reveal some of the biological factors that contribute to the 
variability in its functioning. Taken together, these results suggest that someone’s genetic makeup 
and usual hormonal milieu may determine the preferential responsivity of one’s amygdala, but that 
changes in one’s hormonal levels may overrule this preferential response. Moreover, as illustrated 
by the sex-specific influence of the BDNF  gene on amygdala function (see Chapter 2), the 
interplay between these factors could be particularly important. This example suggests that the 
hormonal background influences the impact of genetic variability, but it may also go the other way 
around. The gonadal hormone fluctuations across the menstrual cycle affects the amygdala 
differently in women with PMDD (Protopopescu et al., 2008), who are more susceptible to the 
effects of these hormones (Schmidt et al., 1998). These individual differences in hormone 
sensitivity could be determined by differences in genetic make-up (Huo et al., 2007).
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These sex hormone and sex-dependent gene effects on amygdala function may explain the 
differences in amygdala reactivity between men and women (Sergerie et al., 2008), which may 
subsequently contribute to sex differences in the susceptibility to certain psychiatric disorders 
(Kessler et al., 2005). For example, women are approximately twice more likely to develop 
depression. Strikingly, this difference begins at menarche and is attenuated after menopause 
(Steiner et al., 2003; Weissman & Olfson, 1995), indicating an important role for female sex 
hormones in the pathophysiology of mood disorders. A potential underlying mechanism could be 
that these hormones change the sensitivity of the amygdala, and thereby determine the 
consequences of stress (Ossewaarde et al., 2008).
Because increased amygdala activity is thought to represent a vulnerability factor for mood 
and anxiety disorders in both men and women (Stein et al., 2007b), it is currently unclear why 
women usually have smaller amygdala responses than men (Sergerie et al., 2008). One possibility is 
that the hormonal fluctuations during the menstrual cycle and hormonal contraceptive use are of 
influence. For example, amygdala responses are reduced during the follicular and midcycle phases 
of the menstrual cycle (Goldstein et al., 2005; Ossewaarde et al., 2008). This is in line with studies 
that have investigated hypothalamus-pituitary-adrenal (HPA) axis responsivity, which is modulated 
by the amygdala (Herman et al., 2005). Women usually have lower HPA axis responses to 
psychological stressors than men (Kajantie & Phillips, 2006; Kudielka & Kirschbaum, 2005). 
However, if the menstrual cycle is taken into account, women indeed have lower HPA axis 
responses during the follicular phase, but not during the luteal phase (Kirschbaum et al., 1999). 
Moreover, HPA axis responses appear even further reduced in women taking oral contraceptives 
(Kirschbaum et al., 1999). Therefore, menstrual cycle effects and hormonal contraceptive use may 
explain part of the reduced amygdala responsivity in women.
An important open question is whether individual differences in amygdala activity are related 
to differences in amygdala volume. For example, men not only show larger amygdala responsivity 
than women, they also have larger amygdala volumes (Goldstein et al., 2001). Furthermore, the 
abnormal amygdala functioning during a first major depressive episode (see Chapter 6) goes along 
with increased amygdala size during the depressive state (van Eijndhoven et al., 2008). One 
preliminary study suggested that amygdala volume may determine amygdala activity in depressed 
but not healthy individuals (Siegle, Konecky, Thase, & Carter, 2003), whereas another recent study 
suggests that amygdala gray matter volume may also explain amygdala responsivity in healthy 
volunteers (Gianaros et al., 2008). But whereas amygdala responses were determined by amygdala 
volume in the study by Gianaros and colleagues, the sex-dependent BDNF  genotype effects 
described in Chapter 2 were not explained by differences in (relative) amygdala volume. Future 
studies may further investigate amygdala structure-function relationships, and determine whether 
this is altered in depressed patients.
Although the studies in this thesis have focused on amygdala function, it is only part o f a 
larger emotion circuitry. The amygdala is a critical component involved in the identification of the 
emotional significance of stimuli and the generation of affective responses. Other brain regions of 
this circuitry, mainly areas o f the prefrontal cortex, are more involved in the regulation of emotion
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and amygdala functioning (Phillips et al., 2003a). Therefore, genes and hormones not only affect 
amygdala activity, but also its interaction with other parts of the circuitry. For example, the effects 
of a variation in the serotonin transporter gene (Heinz et al., 2005) and progesterone (see Chapter 
3) on amygdala activity coincide with altered functional coupling with the prefTontal cortex. This 
suggests that the modulation o f amygdala activity may subsequently also influence prefrontal 
function, or that increased amygdala activity could be the result of altered prefrontal regulation. 
Furthermore, studies with depressed patients have demonstrated that patients with lower 
functional coupling report more symptoms (Matthews, Strigo, Simmons, Yang, & Paulus, 2008), 
which suggests that reduced prefrontal regulation of amygdala activity could be critical in the 
development of depressive symptoms. Thus, to better understand the influence of the amygdala on 
behavior and psychopathology, it is also important to consider its interaction with other regions of 
the neural circuitry.
The studies described in this thesis demonstrate that genes and hormones contribute to the 
variability in amygdala reactivity across and within individuals. But besides these biological factors, 
environmental factors are also o f influence. For example, premature birth reduces amygdala 
volume in children (Peterson et al., 2000), and early life stress affects amygdala development in 
rodents (Teicher et al., 2003). Furthermore, life stress moderates the effects o f a variation in the 
serotonin transporter gene on amygdala responsivity (Canli et al., 2006) and depression 
vulnerability (Caspi et al., 2003). Thus, amygdala functioning is not fully determined by the biology, 
but is dependent on complex interactions between biological and environmental factors, and may 
change after the experience of positive or negative life events. It may be this interaction between 
biological and environmental factors that is particularly important to explain individual differences 
in amygdala functioning, and to understand why some individuals are more vulnerable to stress 
than others.
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De amygdala is een amandelvormige hersenstructuur diep in het brein. Deze structuur werd voor 
het eerst beschreven door Burdach in het begin van de 19e eeuw die het de naam “Mandelkern” 
gaf. Uit onderzoek later die eeuw door Brown en Schäfer, die bij apen een gedeelte van de 
hersenen waaronder de amygdala verwijderden, bleek dat het hersengebied waar de amygdala deel 
van uit maakt belangrijk is voor emotioneel en sociaal gedrag. De specifieke gedragsveranderingen 
die ontstonden na verwijdering van dit deel van de hersenen werden meer uitvoerig beschreven 
door Klüver en Bucy in 1939. Enkele jaren later demonstreerde Weiskrantz dat die gedragseffecten 
voornamelijk het gevolg waren van schade aan de amygdala.
Meer recent onderzoek heeft laten zien dat de amygdala ook heel belangrijk is voor 
emotioneel gedrag bij mensen, zoals voor het begrijpen van sociale signalen en het herinneren van 
emotionele gebeurtenissen. Dit is eerst onderzocht bij patiënten met een zeer zeldzame ziekte 
(Urbach-Wiethe) die daardoor specifieke schade aan de amygdala hebben. Door de ontwikkeling 
van functionele neuroimaging technieken kon dit later ook worden onderzocht bij gezonde 
mensen. Uit deze onderzoeken is gebleken dat de amygdala belangrijk is voor vrijwel alle mentale 
processen wanneer er emotie in het spel komt. Een recente theorie van Whalen stelt daarom ook 
dat de amygdala vooral belangrijk is voor de detectie van belangrijke en mogelijk bedreigende 
stimuli, om vervolgens de verwerking van die stimuli te bevorderen.
Hoewel de amygdala zeer belangrijk is voor de verwerking van emotie, zijn er toch grote 
verschillen tussen individuen in het functioneren van hun amygdala. Daar spelen verschillende 
factoren een belangrijke rol bij, die worden onderverdeeld in zogenaamde “state” en “trait” 
factoren. Trait factoren zijn stabiele kenmerken zoals iemands geslacht of andere genetische aanleg, 
maar ook relatief stabiele kenmerken zoals iemands leeftijd of persoonlijkheid. State factoren 
daarentegen zijn afhankelijk van de situatie waarin iemand zich begeeft, bijvoorbeeld het al dan niet 
uitgerust zijn of het ervaren van een stressvolle gebeurtenis, maar ook de periode van de 
menstruele cyclus van de vrouw. Al deze factoren hebben invloed op het functioneren van de 
amygdala, en die gezamenlijk het verschil in functioneren van de amygdala tussen individuen 
kunnen verklaren.
Deze verschillen worden pas echt duidelijk bij patiënten met een psychiatrische stoornis. De 
amygdala functioneert anders bij patiënten met angst- en stemmingsstoornissen, maar ook bij 
patiënten met autisme en schizofrenie. De vraag is echter of amygdala disfunctie een trait factor is, 
die de kwetsbaarheid voor het ontwikkelen van een psychische stoornis verhoogt, of dat het 
voornamelijk een state factor is die samengaat met de mate van symptomen. Dit kan worden 
onderzocht door depressieve patiënten te onderzoeken voor en na een depressieve episode, 
waardoor kan worden gekeken of amygdala disfunctie vermindert met het verminderen van de 
symptomen, of dat het nog steeds aanwezig is na het herstellen van een depressie.
Het doel van dit proefschrift was om de invloed van verschillende state en trait factoren op 
het functioneren van de amygdala te onderzoeken, die deels het verschil in amygdala functie tussen
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individuen kunnen verklaren. Enerzijds hebben we de invloed van genetische en hormonale 
factoren die betrokken zijn bij depressie onderzocht bij gezonde mensen. Anderzijds hebben we 
depressieve patiënten onderzocht waarvan de ene helft een eerste depressieve episode doormaakte 
en de andere helft net was hersteld, en beide groepen hebben we vergeleken met gezonde 
vrijwilligers, om te onderzoeken of amygdala disfunctie afhankelijk is van de stemming of dat het 
meer een kwetsbaarheidsfactor is.
In hoofdstuk 2 hebben we de invloed van de verandering van één nucleotide in het DNA van 
het brain-derived neurotrophic factor (BDNF) gen op de amygdala onderzocht bij gezonde 
vrijwilligers. BDNF is een eiwit dat heel belangrijk is voor de verbinding tussen neuronen 
(synaptische plasticiteit). Uit eerder onderzoek was gebleken dat deze genetische verandering bij 
mannen zorgt voor een verhoogd risico op depressie. Omdat de amygdala betrokken is bij 
depressie, maar ook bij de vorming van herinneringen voor emotionele gebeurtenissen, hebben wij 
onderzocht of deze verandering in het BDNF  gen (Val66Met) tot een andere geheugenfunctie van 
de amygdala leidt. We hebben daarvoor mensen gevraagd plaatjes van gezichten te onthouden en 
later te herkennen, terwijl we hun hersenactiviteit maten met functionele MRI (fMRI). Uit ons 
onderzoek blijkt dat de amygdala van mannen met het risico-allel minder efficiënt emotioneel 
geladen plaatjes opslaat, wat mogelijk het verhoogde risico op depressie kan verklaren.
In hoofdstukken 3 en 4 hebben we de effecten van het hormoon progesteron op de amygdala 
onderzocht. Het progesteronniveau verandert gedurende de menstruele cyclus, wat bij vrouwen 
met het premenstrueel syndroom leidt tot stemmingsklachten. Om te onderzoeken hoe dat kan, 
hebben we gezonde vrouwen het hormoon toegediend en de reactie van hun amygdala op plaatjes 
gemeten met fMRI. In een lage concentratie, vergelijkbaar met die tijdens de menstruele cyclus, 
zorgde progesteron voor een verhoging van de activiteit, wat mogelijk voor de verhoogde 
prikkelbaarheid kan zorgen. Echter, tijdens een hoge concentratie, vergelijkbaar met die tijdens de 
zwangerschap, verlaagde de activiteit van de amygdala, wat zorgde voor een verslechtering van het 
geheugen.
De concentratie van testosteron neemt af met leeftijd, wat samen gaat met een afname van 
amygdala activiteit en een afname van het aantal mensen met een depressie. In hoofdstuk 5 hebben 
we onderzocht of dat door het effect van testosteron op de amygdala zou kunnen komen. De 
afname van testosteron met toenemende leeftijd voorspelde de afname in amygdala activiteit bij 
gezonde vrouwen. Om te onderzoeken of dit een direct effect van testosteron zou kunnen zijn, 
hebben we ook testosteron toegediend bij vrouwen van middelbare leeftijd. Daardoor nam hun 
amygdala activiteit toe tot het niveau van gezonde jonge vrouwen.
In hoofdstuk 6 hebben we onderzocht of amygdala disfunctie bij depressieve patiënten 
afhankelijk is van hun stemming, of dat het ook aanwezig is na herstel. Met andere woorden, of er 
dus of er sprake is van een state of trait factor. Eerder onderzoek heeft laten zien dat de amygdala 
harder moet werken bij depressieve patiënten om emotionele informatie te onthouden. Wij hebben 
mensen die voor een eerste keer een depressie doormaakten, mensen die net waren hersteld van 
een eerste depressie, en gezonde mensen gevraagd plaatjes van blije en neutrale gezichten te 
onthouden en herkennen, en weer hersenactiviteit gemeten met fMRI. Uit ons onderzoek blijkt dat
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de amygdala van depressieve patiënten vooral harder moet werken om de blije gezichten, dus 
stemmings-incongruente informatie, te onthouden en te herkennen. Dit was niet meer het geval bij 
de herstelde patiënten, dus afhankelijk van de stemming, ofwel een state factor.
Uit de resultaten van dit proefschrift blijkt dat genetische en hormonale factoren het 
functioneren van de amygdala beïnvloeden. Individuele verschillen in deze factoren dragen 
daardoor bij aan het verschil in amygdala functie tussen individuen. Maar niet alleen biologische 
factoren zijn van belang. Omgevingsfactoren hebben ook invloed op de werking van de amygdala, 
en zorgen soms voor een andere uitwerking van deze biologische factoren. Het zal voor 
vervolgonderzoek vooral van belang zijn om te onderzoeken hoe de interactie tussen biologische 
en omgevingsfactoren iemand kwetsbaar maakt voor het ontwikkelen van een psychische stoornis.
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